WO2003002466A1 - Procede d'antioxydation et eau a fonction antioxydante - Google Patents
Procede d'antioxydation et eau a fonction antioxydante Download PDFInfo
- Publication number
- WO2003002466A1 WO2003002466A1 PCT/JP2002/006560 JP0206560W WO03002466A1 WO 2003002466 A1 WO2003002466 A1 WO 2003002466A1 JP 0206560 W JP0206560 W JP 0206560W WO 03002466 A1 WO03002466 A1 WO 03002466A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- water
- hydrogen
- antioxidant
- dissolved
- catalyst
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 636
- 229910001868 water Inorganic materials 0.000 title claims abstract description 626
- 238000000034 method Methods 0.000 title claims abstract description 65
- 230000003064 anti-oxidating effect Effects 0.000 title claims abstract description 7
- 230000003078 antioxidant effect Effects 0.000 title claims description 112
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 226
- 239000001257 hydrogen Substances 0.000 claims abstract description 173
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 173
- 239000003054 catalyst Substances 0.000 claims abstract description 92
- 230000002829 reductive effect Effects 0.000 claims abstract description 47
- 238000006243 chemical reaction Methods 0.000 claims abstract description 38
- 239000000758 substrate Substances 0.000 claims abstract description 38
- 230000008569 process Effects 0.000 claims abstract description 17
- 230000007812 deficiency Effects 0.000 claims abstract description 8
- 239000000084 colloidal system Substances 0.000 claims description 131
- 239000003963 antioxidant agent Substances 0.000 claims description 112
- 235000006708 antioxidants Nutrition 0.000 claims description 112
- 230000009467 reduction Effects 0.000 claims description 86
- 238000011282 treatment Methods 0.000 claims description 63
- 108010020056 Hydrogenase Proteins 0.000 claims description 48
- 229910000510 noble metal Inorganic materials 0.000 claims description 32
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 24
- 238000004140 cleaning Methods 0.000 claims description 21
- 230000003647 oxidation Effects 0.000 claims description 21
- 238000007254 oxidation reaction Methods 0.000 claims description 21
- 150000002431 hydrogen Chemical class 0.000 claims description 20
- 239000003638 chemical reducing agent Substances 0.000 claims description 19
- 239000010970 precious metal Substances 0.000 claims description 19
- 108090000854 Oxidoreductases Proteins 0.000 claims description 16
- 102000004316 Oxidoreductases Human genes 0.000 claims description 16
- 238000002347 injection Methods 0.000 claims description 16
- 239000007924 injection Substances 0.000 claims description 16
- 235000010323 ascorbic acid Nutrition 0.000 claims description 11
- 239000011668 ascorbic acid Substances 0.000 claims description 11
- 238000005406 washing Methods 0.000 claims description 9
- 229960005070 ascorbic acid Drugs 0.000 claims description 8
- 230000035622 drinking Effects 0.000 claims description 8
- 235000013305 food Nutrition 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000002537 cosmetic Substances 0.000 claims description 6
- 238000010894 electron beam technology Methods 0.000 claims description 5
- 238000001802 infusion Methods 0.000 claims description 5
- 230000035484 reaction time Effects 0.000 claims description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims description 3
- 229940072107 ascorbate Drugs 0.000 claims description 3
- 238000000502 dialysis Methods 0.000 claims description 3
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 claims description 3
- 229940048910 thiosulfate Drugs 0.000 claims description 3
- 239000008151 electrolyte solution Substances 0.000 claims description 2
- VBYZSBGMSZOOAP-UHFFFAOYSA-N molecular hydrogen hydrate Chemical compound O.[H][H] VBYZSBGMSZOOAP-UHFFFAOYSA-N 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 120
- 238000012360 testing method Methods 0.000 description 100
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 96
- 239000007864 aqueous solution Substances 0.000 description 93
- 229960000907 methylthioninium chloride Drugs 0.000 description 92
- 238000006722 reduction reaction Methods 0.000 description 86
- 230000001603 reducing effect Effects 0.000 description 73
- 238000005868 electrolysis reaction Methods 0.000 description 72
- 230000008859 change Effects 0.000 description 70
- 230000010757 Reduction Activity Effects 0.000 description 54
- 238000002835 absorbance Methods 0.000 description 54
- 239000000243 solution Substances 0.000 description 54
- 239000012086 standard solution Substances 0.000 description 50
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 45
- 239000000523 sample Substances 0.000 description 43
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 41
- 239000001301 oxygen Substances 0.000 description 41
- 229910052760 oxygen Inorganic materials 0.000 description 41
- 238000011156 evaluation Methods 0.000 description 36
- -1 hydroxyl radicals Chemical class 0.000 description 34
- 239000000126 substance Substances 0.000 description 34
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 33
- 238000007872 degassing Methods 0.000 description 30
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 29
- 210000004027 cell Anatomy 0.000 description 28
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 26
- 238000011049 filling Methods 0.000 description 26
- 230000006870 function Effects 0.000 description 25
- 239000000975 dye Substances 0.000 description 21
- 239000007800 oxidant agent Substances 0.000 description 21
- 239000012528 membrane Substances 0.000 description 20
- 238000003860 storage Methods 0.000 description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
- 239000003643 water by type Substances 0.000 description 18
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 17
- 230000000694 effects Effects 0.000 description 17
- 102000004190 Enzymes Human genes 0.000 description 15
- 108090000790 Enzymes Proteins 0.000 description 15
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 15
- 229910052710 silicon Inorganic materials 0.000 description 15
- 239000010703 silicon Substances 0.000 description 15
- 230000000704 physical effect Effects 0.000 description 14
- 238000005259 measurement Methods 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 229910001873 dinitrogen Inorganic materials 0.000 description 12
- 239000007789 gas Substances 0.000 description 12
- 150000002500 ions Chemical class 0.000 description 12
- 230000002292 Radical scavenging effect Effects 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 230000001590 oxidative effect Effects 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- QTWZICCBKBYHDM-UHFFFAOYSA-N leucomethylene blue Chemical compound C1=C(N(C)C)C=C2SC3=CC(N(C)C)=CC=C3NC2=C1 QTWZICCBKBYHDM-UHFFFAOYSA-N 0.000 description 9
- 239000008213 purified water Substances 0.000 description 9
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 239000000654 additive Substances 0.000 description 8
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 8
- 229910052742 iron Inorganic materials 0.000 description 8
- 230000033116 oxidation-reduction process Effects 0.000 description 8
- 238000004445 quantitative analysis Methods 0.000 description 8
- 239000004065 semiconductor Substances 0.000 description 8
- 230000009471 action Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000011259 mixed solution Substances 0.000 description 7
- 229910052763 palladium Inorganic materials 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 239000008399 tap water Substances 0.000 description 7
- 235000020679 tap water Nutrition 0.000 description 7
- 108091006149 Electron carriers Proteins 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 230000004913 activation Effects 0.000 description 6
- 230000003197 catalytic effect Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 229910052697 platinum Inorganic materials 0.000 description 6
- 239000010453 quartz Substances 0.000 description 6
- 238000006479 redox reaction Methods 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 5
- 244000309464 bull Species 0.000 description 5
- 238000004364 calculation method Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000008034 disappearance Effects 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 230000037149 energy metabolism Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000007613 environmental effect Effects 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- SXZYCXMUPBBULW-SKNVOMKLSA-N L-gulono-1,4-lactone Chemical compound OC[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O SXZYCXMUPBBULW-SKNVOMKLSA-N 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 235000013373 food additive Nutrition 0.000 description 4
- 239000002778 food additive Substances 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 229960003180 glutathione Drugs 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 230000020192 tolerance induction in gut-associated lymphoid tissue Effects 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 108010024636 Glutathione Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 238000005341 cation exchange Methods 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- KYKAJFCTULSVSH-UHFFFAOYSA-N chloro(fluoro)methane Chemical compound F[C]Cl KYKAJFCTULSVSH-UHFFFAOYSA-N 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 210000002249 digestive system Anatomy 0.000 description 3
- 235000003969 glutathione Nutrition 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000010534 mechanism of action Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000006174 pH buffer Substances 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 239000007784 solid electrolyte Substances 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 2
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 description 2
- 229920000557 Nafion® Polymers 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241001061127 Thione Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 235000020682 bottled natural mineral water Nutrition 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000000385 dialysis solution Substances 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 229910001882 dioxygen Inorganic materials 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000005429 filling process Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000002440 industrial waste Substances 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000008239 natural water Substances 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000011176 pooling Methods 0.000 description 2
- 235000019353 potassium silicate Nutrition 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- YNCMLFHHXWETLD-UHFFFAOYSA-N pyocyanin Chemical compound CN1C2=CC=CC=C2N=C2C1=CC=CC2=O YNCMLFHHXWETLD-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000027756 respiratory electron transport chain Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 229910052814 silicon oxide Inorganic materials 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- MASUWVVNWALEEM-UHFFFAOYSA-M 1-methoxy-5-methylphenazin-5-ium;methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2N=C3C(OC)=CC=CC3=[N+](C)C2=C1 MASUWVVNWALEEM-UHFFFAOYSA-M 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- RUKISNQKOIKZGT-UHFFFAOYSA-N 2-nitrodiphenylamine Chemical compound [O-][N+](=O)C1=CC=CC=C1NC1=CC=CC=C1 RUKISNQKOIKZGT-UHFFFAOYSA-N 0.000 description 1
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 208000031872 Body Remains Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011951 Decompression Sickness Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229910015400 FeC13 Inorganic materials 0.000 description 1
- 229920003935 Flemion® Polymers 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229930189936 Glyoxalase Natural products 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000026062 Tissue disease Diseases 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 1
- QQOPAWAPLFHEEP-UHFFFAOYSA-M [7-(dimethylamino)-2-methylphenoxazin-3-ylidene]-diethylazanium;chloride Chemical compound [Cl-].O1C2=CC(N(C)C)=CC=C2N=C2C1=CC(=[N+](CC)CC)C(C)=C2 QQOPAWAPLFHEEP-UHFFFAOYSA-M 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000019846 buffering salt Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000010349 cathodic reaction Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 150000001945 cysteines Chemical class 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000214 effect on organisms Effects 0.000 description 1
- 238000003411 electrode reaction Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- SQHOAFZGYFNDQX-UHFFFAOYSA-N ethyl-[7-(ethylamino)-2,8-dimethylphenothiazin-3-ylidene]azanium;chloride Chemical compound [Cl-].S1C2=CC(=[NH+]CC)C(C)=CC2=NC2=C1C=C(NCC)C(C)=C2 SQHOAFZGYFNDQX-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- UQSQSQZYBQSBJZ-UHFFFAOYSA-N fluorosulfonic acid Chemical compound OS(F)(=O)=O UQSQSQZYBQSBJZ-UHFFFAOYSA-N 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- KHLVKKOJDHCJMG-QDBORUFSSA-L indigo carmine Chemical compound [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 description 1
- 229960003988 indigo carmine Drugs 0.000 description 1
- 235000012738 indigotine Nutrition 0.000 description 1
- 239000004179 indigotine Substances 0.000 description 1
- 239000010842 industrial wastewater Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000008531 maintenance mechanism Effects 0.000 description 1
- 239000002906 medical waste Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229940006272 methylene blue cation Drugs 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000005036 potential barrier Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229910052702 rhenium Inorganic materials 0.000 description 1
- WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000005469 synchrotron radiation Effects 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 150000003608 titanium Chemical class 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000010938 white gold Substances 0.000 description 1
- 229910000832 white gold Inorganic materials 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/467—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis by electrochemical disinfection; by electrooxydation or by electroreduction
- C02F1/4676—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis by electrochemical disinfection; by electrooxydation or by electroreduction by electroreduction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/68—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/70—Treatment of water, waste water, or sewage by reduction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/005—Systems or processes based on supernatural or anthroposophic principles, cosmic or terrestrial radiation, geomancy or rhabdomancy
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/30—Treatment of water, waste water, or sewage by irradiation
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/30—Treatment of water, waste water, or sewage by irradiation
- C02F1/32—Treatment of water, waste water, or sewage by irradiation with ultraviolet light
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/02—Non-contaminated water, e.g. for industrial water supply
- C02F2103/026—Treating water for medical or cosmetic purposes
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2209/00—Controlling or monitoring parameters in water treatment
- C02F2209/04—Oxidation reduction potential [ORP]
Definitions
- the present invention promotes a reaction of decomposing molecular hydrogen as a substrate contained in the hydrogen-dissolved water into active hydrogen as a product through a process of causing a catalyst to act on the hydrogen-dissolved water, thereby producing electrons.
- the present invention relates to an antioxidant method capable of converting an antioxidant target which is in an oxidized state due to deficiency or which is desired to be protected from oxidation into an electron-filled reduced state, and an antioxidant functional water.
- oxygen is a double-edged sword for living organisms.
- Oxygen is used for the purpose of oxidizing nutrients to obtain energy, or for performing various oxygenation reactions essential for living organisms, but involves the risk of causing various tissue disorders due to its oxidizing power It has been pointed out that.
- active oxygen called superoxide, which is generated by metabolism, is reduced by metal catalysts such as iron and copper to hydrogen peroxide, and becomes highly reactive hydroxyl radicals, which denature proteins and reduce DNA chains. It is known that by cleaving or oxidizing lipids, lipid peroxides, which are considered as aging factors, are produced.
- SOD superoxide dismutase
- Antioxidants such as BHA (butyl hydroxanisol), BHT (butylhydroxytoluene), hytotocophore, ascorbic acid, cysteine, and glutathione are substances that improve such various diseases caused by active oxygen. Or active oxygen Additives are known.
- antioxidants and the like are chemically synthesized products, there is a problem that if they are used in large quantities, their safety to the human body remains questionable. In addition, these antioxidants and the like are oxidized themselves during the process of reducing the other party, but there is also a problem that the safety of such by-product oxides to the human body is concerned.
- the present invention has been made in order to solve such a problem.
- molecular hydrogen as a substrate contained in the hydrogen-dissolved water is converted into active hydrogen as a product.
- Antioxidants that are in an oxidized state due to deficiency of oxygen or that are desired to be protected from acid are placed in a reduced state that is filled with electrons, which is expected to achieve a high level of safety to the human body and reduction of environmental load.
- the purpose is to provide an antioxidant method and an antioxidant functional water.
- the applicant of the present application has filed a re-published patent WO99 / 120286 in which the content is incorporated into the present invention by this citation, and the hydrogen ion index (hereinafter referred to as “p H ”) and an oxidation-reduction potential (hereinafter referred to as” ORP ”) can be controlled independently of each other.
- the outline of the application is as follows. That is, it has an electrolysis chamber into which raw water is introduced, and at least a pair of electrode plates provided between the electrolysis chamber and the outside of the electrolysis chamber with a diaphragm interposed therebetween, and the electrode outside the electrolysis chamber (open system). A plate is provided in contact with the diaphragm or with a small gap therebetween.
- the electrode plate provided inside the electrolytic chamber is used as a cathode while the electrode plate provided outside the electrolytic chamber is used as an anode, and a voltage is applied between both electrodes.
- a power supply circuit for applying the electric current, and an electrolytic cell and a reduction potential water generation device On the cathode side of the device, electrolytic reduction potential water (hereinafter, sometimes referred to as “reduction potential water”) whose ORP is greatly reduced to a negative value is generated without largely changing the pH of the raw water.
- ⁇ electrolysis '' refers to continuous water electrolysis at a flow rate of 1 liter per minute and a constant current of 5 A using the reduction potential water generator described above. To do.
- the present inventors have arrived at the present invention through a performance evaluation test of reduction potential water generated by the above-described reduction potential water generator.
- the reducing potential water is a water whose ORP has a negative value and whose 0 RP value corresponding to pH exceeds a predetermined value.
- '0 Whether the RP value exceeds a predetermined value is determined from the following Nernst equation (approximate equation).
- ORP -59 pH -80 (mV) ⁇ (Nernst equation) As shown in Fig. 1, this equation shows a proportional relationship between pH and ORP (the ORP value becomes more negative as pH becomes more alkaline). ).
- the expression that the ORP value corresponding to the pH exceeds a predetermined value means that the ORP value is lower than the value according to the above-mentioned Nernst equation.
- water that satisfies these conditions is called reduced potential water.
- the ORP becomes about -493 (mV).
- water with an ORP of about -493 (mV) or less corresponds to reduction potential water.
- there is a strict difference in the concentration of dissolved hydrogen which will be described in detail later along with the quantitative analysis method for the concentration of dissolved hydrogen. I do.
- ORP is an index indicating the ratio of the oxidized substance to the reduced substance contained in the liquid to be measured, and its unit is generally milliport (mV).
- mV milliport
- a negative ORP value is observed when the measurement electrode is negatively charged
- a positive ORP value is observed when the measurement electrode is positively charged.
- the fact that the negative absolute value of the ORP value indicates a large value necessarily means that the liquid to be measured contains high-energy electrons.
- a lighting test using a light-emitting diode (hereinafter abbreviated as “LED”) was performed.
- LED light-emitting diode
- the cathode chamber has an ORP of -600 (mV )
- the anode chamber for example, tap water with an ORP of about +400 (mV) .
- the negative electrode of the LED 211 is connected to the electrode that contacts the cathode chamber 205.
- an alkaline electrolyzed water (for example, ORP is about 15 OmV) generated by a commercially available electrolyzed water generator or a natural mineral water is used as an anode chamber in the P bath electrode room.
- ORP is about 15 OmV
- a commercially available electrolyzed water generator or a natural mineral water is used as an anode chamber in the P bath electrode room.
- the absolute value of the 0 RP value at the pH value at that time is calculated according to the above-mentioned Nernst equation, even if the flow rate is reduced and the ORP value is largely moved to the negative side. If it is small, no LED lighting is observed. This is because, for example, in a commercially available electrolyzed water generator, even if the ORP value is about 500 and the ORP value is --500 to 600 (mV) as a result of reducing the flow rate, the ORP value is small instead of the pH value.
- the reduction potential water has a high terminal-to-terminal voltage of about 3 V or more. Continuous lighting of a diode showing a color such as blue or green, which requires the following, was observed.
- the essence of the action of an enzyme is the catalysis of a chemical reaction, and the activity of the enzyme is measured by the speed of the catalyzed reaction.
- A is the substrate and B is the product. If this is applied to the case of the present invention, molecular hydrogen contained in hydrogen-dissolved water corresponds to the substrate, while active hydrogen corresponds to the product.
- the mechanism of action of these enzymes is explained as follows. I thought I could.
- the activation energy corresponding to the height of the wall can be reduced, and as a result, the electrons contained in the reduction potential water are compared with those without a catalyst.
- the transfer to the oxidizing agent can be performed quite smoothly, and when this transfer is completed, the reducing potential water can reduce the oxidizing agent.
- the reaction of decomposing molecular hydrogen as a substrate contained in the hydrogen-dissolved water into active hydrogen as a product is promoted through the process of causing a catalyst to act on the hydrogen-dissolved water.
- the antioxidant that is in an oxidized state due to electron deficiency, or that is desired to be protected from oxidation, is reduced to an electron-filled state.
- the present inventors have obtained the belief that the nature of the negative value of the 0 RP value of hydrogen-dissolved water such as electrolyzed water and hydrogen bubbling water is hydrogen dissolved in the water.
- antioxidants Another important factor is the presence of antioxidants. If there is no antioxidant target, there is no scene where the antioxidant effect according to the present invention is exhibited.
- antioxidant function means that an antioxidant target which is in an oxidized state due to electron deficiency or which is desired to be protected from oxidation is brought into a reduced state in which electrons are satisfied.
- the magnitude of the reducing power here can be estimated for the time being based on the state of the ORP value (stability of the measured ORP value, the relationship with the above-mentioned Nernst equation, etc.), but ultimately, it will be described in detail later. It is determined depending on the effective value of the dissolved hydrogen concentration DH obtained by using the dissolved hydrogen concentration determination method using the redox dye described above.
- Hydrogen-dissolved water is assumed to be any water containing hydrogen.
- the water here (sometimes called raw water) means tap water, purified water, distilled water, natural water, activated carbon treated water, ion-exchanged water, pure water, ultrapure water, and commercially available plastic bottles.
- Water, living body described later Includes all water, including water and water that generates molecular hydrogen by a chemical reaction in water.
- the general range of water obtained by adding an electrolysis assistant or a reducing agent to be described later to such water is also included in the technical scope of the present invention.
- the antioxidant function developed by applying the present invention is derived from the electrons emitted in the process of replacing molecular hydrogen with active hydrogen via a catalyst, so that the dissolved concentration of molecular hydrogen decreases. The higher the value, the higher the antioxidant function can be expected.
- hydrogen-dissolved water refers to the alkaline electrolyzed water generated on the cathode side when the raw water is electrolyzed between the anode and the cathode through a diaphragm, or the hydrogen is not bubbled (aerated) to the raw water.
- water treated by pressure filling and the like This definition is based on the so-called Al-ion water produced by existing continuous-flow or batch-type electrolyzed water generators, and hydrogen-dissolved water produced by adding hydrogen to raw water by external operation. It is intended to clarify that it is within the technical scope of the present invention. What is listed here as hydrogen-dissolved water is merely an example, and is not intended to be limited to these. Therefore, it should be clarified that even if natural water contains hydrogen, such water is not intended to be excluded from the technical scope of the present invention.
- intestinal microorganisms in particular, molecular hydrogen that is presumed to be produced by a hydrogenase-containing microorganism, are dissolved in body fluids such as blood and lymph of a living body (sometimes referred to as biological water).
- body fluids such as blood and lymph of a living body
- hydrogen-dissolved water encompasses biological water, in which molecular hydrogen is dissolved regardless of its origin, within the technical range.
- the location of molecular hydrogen in living organisms is not limited to the intestine, but is absorbed from the intestinal tract and distributed in the blood. It is considered that it is sent to each internal organ official and stored in each part of the body.
- molecular hydrogen existing in the living body as a reducing agent
- the activation of molecular hydrogen is performed by administering an enzyme such as a hydrogenase or a noble metal colloid described below to the living body. You can promote it.
- reduction potential water as used herein includes water generated by a reduction potential water generator (hereinafter simply referred to as “reduction potential water generator”) developed by the present applicant, and naturally includes other water.
- the target waters for comparison were activated carbon treated water obtained by passing Fujisawa tap water through an activated carbon power ram, purified purified water obtained by passing Fujisawa tap water through an organo ion exchange column, and
- evian registered trademark of SAdes Eaux Minrales d, Evian supplied in Japan by Calpis Itochu Mineral Water Co., Ltd. is illustrated.
- Hydrogen-dissolved water after various treatments for dissolving hydrogen in the water for comparison was performed using a reducing potential water generator developed by the present applicant under electrolysis conditions of 5 A constant current at a flow rate of 1 liter.
- the first reduction potential obtained by performing continuous electrolysis for 30 minutes under the same electrolysis conditions (the amount of circulating water was 2 liters) using the same electrolysis conditions (the amount of circulating water was 2 liters).
- Hydrogen gas publishing water that was subjected to hydrogen gas publishing for 30 minutes for water and various types of water to be compared, and an electrolysis oven with a standard water volume using the Mizu Mini Water Yuichi electrolysis water generator. And alkaline electrolyzed water that has been subjected to continuous electrolysis using the electrolysis conditions of “4”.
- the various physical properties of such water include pH, redox potential ORP (mV), electrical conductivity EC (mS / m), dissolved oxygen concentration D0 (mg / L), dissolved hydrogen Concentration DH (mg / L) and water temperature (° C) are listed.
- the various instruments used to measure these various physical properties include pH meter (including thermometer) manufactured by HORIBA, Ltd. 13 ”, the model of the probe is“ 9620-10D ”.
- the ORP meter is one of Horiba Seisakusho's ⁇ 0 RP meter body model“ D-25 ”and the probe model“ 9300-10D ”.
- the EC meter is the EC meter model “D-24” and the probe model “9382-10D” manufactured by HORIBA, Ltd., and the DO meter is manufactured by HORIBA, Ltd.
- the model of the DO meter body is “D-25”
- the model of the probe is “9520-10D”
- the DH meter (dissolved hydrogen meter) is the body model of TOA DIKK Corporation.
- the same repeater model “DHM-F 2” Various physical properties of the water to be compared were measured using instruments.
- the first reduced potential water that has been electrolyzed once by using the reduced potential water generator is used for the electrolyzed water. It can be seen that despite the fact that can be taken out immediately, some of them can dissolve as high as 0.425 to 0.9000 (mg / L) of hydrogen.
- the treatment time is, for example, 30 minutes, the dissolved hydrogen concentration of the circulating electrolytic reduction potential water (second reduction potential water) and the hydrogen gas publishing water in the reduction potential water generator is compared.
- At least one reducing agent selected from the group including sulfite, thiosulfate, ascorbic acid, and ascorbate is added to the hydrogen-dissolved water as necessary. This is because, when it is necessary to prevent rapid oxidation of active hydrogen due to dissolved oxygen generated by the catalytic action, the dissolved oxygen concentration in the hydrogen-dissolved water is preferably kept as low as possible.
- the dissolved oxygen concentration DO (mg / L ) Can be reduced to almost 0 (mg / L).
- antioxidant-functional water according to the present invention when the antioxidant-functional water according to the present invention is bottled in a state where it is coexisted with additives such as a reducing agent and water-soluble bimin, such additives are placed in an antioxidant environment, resulting in It should be added that there is an aspect that the antioxidant action inherent to the additive can be further enhanced. This is because, when the antioxidant-functional water according to the present invention is bottled in a state where it is coexisted with, for example, reduced ascorbic acid, such ascorbic acid is placed in an antioxidant environment and thus reduced. As a result, it means that reduced ascorbic acid can derive its own antioxidant action more strongly.
- additives such as a reducing agent and water-soluble bimin
- a reducing agent such as reduced ascorbic acid in an excess amount after reducing and neutralizing oxides such as dissolved oxygen in the coexisting system.
- a reducing agent such as reduced ascorbic acid
- neutralizing oxides such as dissolved oxygen
- the catalyst is generally assumed to have a function of catalyzing a reaction of decomposing molecular hydrogen as a substrate contained in the hydrogen-dissolved water into active hydrogen as a product.
- the essence of the catalytic function according to the present invention is to promote the activation of molecular hydrogen smoothly.
- it receives electrons from molecular hydrogen (one molecular hydrogen is activated).
- the catalyst according to the present invention include hydrogen oxidoreductase, more specifically, hydrogenase, a noble metal colloid described below, or at least one electromagnetic wave selected from the group including visible light, ultraviolet light, and electron beam.
- the noble metal colloid assumed in the present invention includes platinum, palladium, rhodium, iridium, ruthenium, gold, silver, rhenium, and colloid particles themselves such as salts, alloy compounds, and complex compounds of these noble metal elements. It is a concept that includes these mixtures.
- the contents of the description are incorporated into the present invention by this citation, "How to make and use Pt colloid" by Seitaro Namba and Ichiro Okura, Surface Vol. 21 No. 8 (1983).
- the colloid referred to in the present invention is assumed to be particles having a diameter of lnm to 0.1, which are generally said to exhibit essential behavior as a colloid.
- the particle diameter at which the catalytic activity of the P colloid increases is preferably in the range of 1 to 10 nm, more preferably 4 to 6 nm. It is believed that there is. This is As described in the paper by Namba et al.
- the particle size can be derived from the trade-off relationship.
- the colloids in the present invention Staudinger of Germany has proposed, "which is composed of 1 0 3 to 1 0 9 atoms is colloidal.” In the definition of the It matches.
- the noble metal colloid according to the present invention preferably has a spherical particle shape in order to increase its surface area. This is because a large surface area of the noble metal colloid means an increase in the chance of contact with molecular hydrogen as a substrate, which is advantageous from the viewpoint of expressing the catalytic function of the noble metal colloid.
- catalyst also includes electron carriers such as coenzymes, inorganic compounds, and organic compounds that supplement their functions.
- Such electron carriers can smoothly receive electrons from an electron donor such as hydrogen, hydrogen oxidoreductase hydrogenase, or a noble metal colloid, and at the same time, transfer the received electrons to an electron acceptor. It is preferable to have the property of smoothly transmitting to the antioxidant target. Put simply, the role of the electron carrier is to transport hydrogen (electrons).
- the electron carrier may be of the oxidized or reduced type, but the reduced type of the electron carrier has surplus electrons in advance, which is advantageous in that it is easier to emit electrons. I can say.
- the reduced methylene bleed is called leucomethylene bleed.
- Phenazine metsulfate tends to be photodegradable.
- FeC13 Fe2 (S04) 3, and Fe (0H) 3.
- FeC13 Fe2 (S04) 3
- Fe (0H) 3 Fe
- the original purpose is to obtain iron (III) ion Fe (3+) as an ion.
- the existence of hemoglobin of erythrocytes as heme iron in living organisms is considered. Hem iron has different properties from an independent iron ion.
- ferrous iron Fe (2+) is a reduced form of ferrous iron Fe (3+), but the reduced form often enhances oxidative effects. Especially when a lipid peroxide is present, a radical chain reaction is likely to occur.
- iron (III) ion F e (3+) is reduced by ascorbic acid or the like, a radical generation chain reaction occurs in the presence of lipid peroxide. In other words, it is thought that many lipid radicals are generated and have a bad effect on the living body.
- SH compounds that are abundant in living organisms, and it is presumed that humans also have genes that synthesize them.
- Glutathione has the function of directly (non-enzymatically) reducing oxygen (02).
- An SH compound one of the amino acids, is the end product of digesting and digesting protein. It is an amino acid having a SH group, which is a constituent element of the above-mentioned glutathione. Again, like glucyan thione, two cysteines, Cys, each emit one hydrogen atom, forming a disulfide bond (—s—s—) to form oxidized cysteine.
- strawberry species Although it is hardly present in living organisms, it is contained in strawberry species at about 0.05%. It is a basic reducing agent and has the function of non-enzymatically and effectively scavenging hydroxyl radicals and converting it to water.
- the alkaline aqueous solution has particularly strong reducing power. Tends to react with oxygen.
- the catalysts listed here are merely examples, and are not intended to limit the scope of the invention. Therefore, it is clarified that the present invention is not intended to exclude other parameters such as temperature, ultrasonic waves, and physical external forces such as agitation as long as the present invention contributes to the envisaged catalytic reaction.
- active hydrogen as a product is a concept that comprehensively includes atomic hydrogen (H ⁇ ) and hydride ions (hydride ions H_).
- the catalysts described here can be used individually alone or, if necessary, can be used in combination of two or more as appropriate. Basically, electrons are transmitted in the order of "hydrogen dissolved water catalyst”> antioxidant.
- hydrogen dissolved water enzyme (hydrogenase) antioxidant hydrogen dissolved water electron transfer Body ⁇ anti Oxidation target, hydrogen-dissolved water "Enzyme (hydrogenase) Electron mediator Antioxidant target, hydrogen-dissolved water Noble metal colloid Antioxidant target, or hydrogen-dissolved water Noble metal colloid Electron mediator ⁇ antioxidant target, etc.
- Antioxidants are intended to cover all objects that are in an oxidized state due to electron deficiency or that are desired to be protected from oxidation.
- oxidation here refers to a phenomenon in which electrons are extracted from an object by direct or indirect action of oxygen, heat, light, pH, ions, or the like.
- the antioxidant target include, for example, living cells or objects to be washed in industrial fields such as industrial washing, food washing or precision washing, and antioxidants such as vitamins, Foods, quasi-drugs, pharmaceuticals, cosmetics, feeds, redox dyes described below, water itself, and the like fall within the technical scope of the present invention. It should be clarified that what is listed here as antioxidant targets is merely an example and is not intended to be limited to these. Next, the relationship between catalysts and antioxidants is described from the viewpoint of catalysts. '
- hydrogen oxidoreductase, hydrogenase, or a noble metal colloid catalyzes a reaction for decomposing molecular hydrogen as a substrate contained in hydrogen-dissolved water into active hydrogen as a product.
- hydrogen oxidoreductase such as hydrogenase is added to reduction potential water.
- hydrogen oxidoreductase such as hydrogenase
- oxidizing agents such as active oxygen coexist in the gastrointestinal and other digestive system living cells (antioxidant targets)
- antioxidant targets such as fruit juice and vitamins (antioxidants)
- the reducing potential water is used as an antioxidant for these additives under the condition that hydrogenase coexists.
- the mechanism of action is that the molecular hydrogen dissolved in the reducing potential water is dissociated into two atomic hydrogens (H ⁇ ) by the hydrogenolytic action of hydrogenase.
- Atomic hydrogen (H ⁇ ) generated in this way is split into protons and electrons in the presence of water, and the resulting electrons are donated to antioxidants (reduction of antioxidants) it is conceivable that.
- a precious metal colloid for example, a platinum colloid added to reduction potential water.
- oxidizing agents such as active oxygen coexist in gastrointestinal and other digestive system living cells (antioxidant targets)
- these are immediately consumed. Will be reduced.
- other additives such as fruit juice and vitamins (antioxidants) coexist
- the reducing potential water is used as an antioxidant for these additives under the condition that the N colloids coexist.
- Act as The mechanism of action is that the molecular hydrogen dissolved in the reduction potential water is adsorbed on the surface of the fine particles of the Pt colloid, and is dissociated into two atomic hydrogens (H.) to be activated. It is thought that hydrogen (H ⁇ ) is split into protons and electrons in the presence of water, and the resulting electrons are donated to antioxidants (reduction of antioxidants).
- This antioxidant function is first manifested by the combination of hydrogen-dissolved water such as reducing potential water, hydrogen oxidoreductase hydrogenase or noble metal colloid as a catalyst, and antioxidant targets such as digestive system living cells. Is done. In other words, it produces reducing power only when necessary, and has no effect when unnecessary. Furthermore, when focusing on the chemical composition, for example, the reduction potential water is just ordinary water obtained by electrolyzing raw water. Therefore, it is important to note that even after the reducing power has been developed, it only acts as normal water and does not have any adverse effect on living organisms. In other words, it is the decisive difference from conventional antioxidants and active oxygen scavengers in that the desired positive effect is obtained but no negative effect, that is, no side effect is present. '
- ATP synthase is the central enzyme in a series of reaction systems for organisms to acquire energy. It is well known that in order to activate this enzyme, a proton concentration gradient must be created inside and outside the cell membrane.Hydrogenase is a membrane protein that exists on the surface of the cell membrane and is a molecular hydrogen around the membrane.
- the inventor of the present invention states, "Hydogenase directly controls the proton concentration gradient inside and outside the membrane to control the action of ATP synthetase. It may play a very important role in the smooth progression of the energy metabolism system in Japan. " That is, the fact that hydrogenase can exert such an effect on organisms means that the antioxidant method of the present invention, the antioxidant functional water, or the expression of the antioxidant function at the cellular level when the biologically applicable water is applied to living cells. In addition, we believe that it supports the smooth promotion of energy metabolism resulting from the improvement of the proton concentration gradient.
- the hydrogen oxidoreductase, hydrogenase or noble metal colloid according to the present invention is associated with or caused by a disease associated with or caused by the function of monocyte macrophage cells, in particular, by an increase or decrease in the function of macrophage cells.
- Disease, tissue Or, it may be opening the way as a medicament for preventing, ameliorating, or treating organ dysfunction or conditions.
- water generally has the property of being able to quickly reach any part of the body, including lipid membranes, cell membranes, and the blood-brain barrier.
- hydrogen oxidoreductase hydrogenase or precious metal colloid By feeding hydrogen oxidoreductase hydrogenase or precious metal colloid together with or separately from hydrogen-dissolved water through operations such as dialysis, a healing effect at the damaged site can be expected.
- the hydrogen oxidoreductase hydrogenase is a protein, and if it is assumed that this is sent to a damaged site in a living body through operations such as injection, infusion, dialysis, etc., the immune system of the living body will be able to transfer the enzyme to the non-self site.
- an antigen-antibody reaction may occur by recognizing that To solve this problem, the principle of oral tolerance in the living body should be applied clinically.
- Oral tolerance refers to antigen-specific T / B cell unresponsiveness induced against foreign antigens that enter orally / enterally.
- oral tolerance is a phenomenon in which even if a substance ingested through the mouth is a protein that can be an antigen, if it is absorbed from the small intestine, it is immune to that substance.
- treatments applying this principle have already been attempted. Therefore, the clinical application of this principle of oral tolerance could open the way to a new therapeutic strategy called antioxidation.
- Electron beam including visible light, ultraviolet light, or X-ray
- a catalyst that catalyzes a reaction for decomposing molecular hydrogen as a substrate contained in hydrogen-dissolved water into active hydrogen as a product is, for example, an electron beam including visible light, ultraviolet light, or X-ray. Line.
- the ultraviolet rays catalyze the dissolved hydrogen in the reduction potential water, releasing the seal of the hydrogen's original reducing power, thereby preventing or reducing the surface of the silicon substrate (antioxidant target) from oxidation.
- a reducing potential water having a pH of 7 to 13. This is because if a solution with a large pH value is used for a silicon substrate, fluorine remaining on the silicon substrate, which is problematic in terms of safety to humans and corrosion of equipment, can be removed. This is because the formation of an oxide film on the surface of the silicon substrate can be prevented.
- Such an antioxidant function is exhibited only by the combination of hydrogen-dissolved water such as reduction potential water, ultraviolet rays as a catalyst, and antioxidant targets such as the surface of a silicon substrate.
- hydrogen-dissolved water such as reduction potential water, ultraviolet rays as a catalyst, and antioxidant targets such as the surface of a silicon substrate.
- the reduction potential water is just ordinary water obtained by electrolyzing raw water. Therefore, even after exerting the reducing power, it only behaves as ordinary water, and has no adverse effect on the surface of the silicon substrate to be cleaned.
- the reduction action suppresses the generation of silicon oxide, it does not produce water glass, which may cause the electrical characteristics of the element to be degraded.
- a hydrogen oxidoreductase that catalyzes a reaction of decomposing molecular hydrogen as a substrate contained in hydrogen-dissolved water into active hydrogen as a product, specifically, For example, hydrogenase or precious metal colloid is added
- An antioxidant-functional water is provided.
- the antioxidant-functional water having such a configuration contains hydrogen-dissolved water and a catalyst among the three important elements of the present invention, the reduction of hydrogen that hydrogen has potentially The seal of force is released, and the antioxidant function unique to the present invention is developed.
- a treatment or operation for adjusting the reaction time of the catalyst is performed on the hydrogen oxidoreductase, hydrogenase, or noble metal chloride as a catalyst.
- the processing or operation for adjusting the reaction time of the catalyst is, for example, as shown in FIG.
- hydrogenase or noble metal colloid is encapsulated in enteric capsules, etc., with the aim of initiating the original catalytic action when it reaches a target site such as the large or small intestine.
- the optimal pH of hydrogenase is around 9, and the optimal temperature is said to be about 49 ° C.
- the treatment or operation for adjusting the reaction time of the catalyst to hydrogenase or the like or its surrounding environment is included in the technical scope of the present invention.
- a food additive that has the function of a dispersant may be appropriately selected from those that have been approved by the Ministry of Health, Labor and Welfare.
- a sucrose fatty acid ester which is low-irritant and widely used for cosmetics and pharmaceuticals is preferably used.
- antioxidant-functional water can be applied in the following industrial fields, for example.
- the first is applications in the fields of medicine and pharmacy. For example, it can be used for infusion production and other pharmaceutical manufacturing processes. It can also be used as an artificial dialysis solution, peritoneal solution, and drug. As a result, it is possible to prevent and treat all diseases caused by active oxygen and to reduce the side effects.
- the second is application as a preventive and therapeutic agent for aging and degeneration caused by oxidation of skin tissue.
- it can be used in the production process of lotions and other cosmetics.
- Third is application as antioxidant foods and functional foods.
- it can be used in the foodstuff manufacturing process.
- Fourth is application in drinking water, processed drinking water and others.
- it can be used as drinking water (antioxidant water) or as a base water for processed drinking water such as canned juice, canned coffee, plastic bottled water, and soft drinks.
- Fifth is the application of food to agricultural chemicals, herbicides, pesticides, etc., to reduce degradation and maintain freshness.
- it can be used as a cleaning solution for vegetables and fruits before shipping.
- Sixth is its application as a substitute for preservatives, preservatives, antioxidants, etc. in the processed food manufacturing process. Specifically, it can be used as a substitute for 347 food additives, for example.
- molecular hydrogen as a substrate contained in the hydrogen-dissolved water is converted into active hydrogen as a product through a process of causing a catalyst to act on the hydrogen-dissolved water.
- the antioxidant that is in an oxidized state due to electron deficiency or that is desired to be protected from oxidation is placed in an electron-filled reduced state, which is safe for the human body. And environmental impact can be reduced at a high level.
- FIG. 1 is a graph showing the Nernst equation
- Fig. 2 is a diagram for explaining a lighting experiment using LEDs
- Fig. 3 is a diagram for explaining an application example of the present invention
- Fig. FIG. 5 is a schematic view showing a semiconductor substrate cleaning system 100 using an oxidation method.
- FIG. 5 is a longitudinal sectional view showing a basic structure of a reduction potential water generator 11 used in a cleaning system 100 or the like according to the present invention.
- Figures 6 and 7 show the evaluation results of the reduction activity of the electrolyzed water added with the Pt colloid catalyst due to the color change of methylene blue.
- Figures 8 and 9 show the pt colloid catalyst due to the color change of methylene blue.
- Figs. 11 show the results of the reduction activity evaluation test of the added hydrogen-dissolved water
- Figs. 10 to 11 show the results of the reduction activity evaluation test of the Pd colloid catalyst-added hydrogen-dissolved water due to the change in color of methylene blue.
- Fig. 13 shows the precious metal mixture (P t + P d) Colloidal catalyst-added hydrogen-dissolved water evaluation test results.
- Fig. 14 shows Pt colloid-catalyzed electrolytically treated water (added before electrolytic treatment / electrolyzed treatment) due to the color change of methylene blue.
- Fig. 15 to Fig. 16 show the results of the evaluation test of the antioxidant activity of the electrolyzed water added with the Pt colloid catalyst due to the color change of the DPPH radical.
- Figs. 10 to 11 show the results of the reduction activity evaluation test of the Pd colloid catalyst-added hydrogen-dissolved water due to the change in color of methylene blue.
- Fig. 13 shows the precious metal mixture (P
- FIG. 17 to 18 show the results of an antioxidant activity evaluation test of catalyst-added hydrogen-dissolved water (degassing treatment and hydrogen gas filling treatment) due to the change in the color change of DPPH radicals.
- Figs. Figure 21 shows the results of a reduction activity evaluation test of hydrogen-dissolved water (degassing treatment + hydrogen gas filling treatment) added with enzyme hydrogenase catalyst by changing the color of Renblue.
- Figures 21 to 22 show dissolved hydrogen by oxidation-reduction dye redox titration.
- Figure used to explain the quantitative concentration analysis method Figure 2 Fig. 3 is a diagram for explaining the comparison between the measured and effective values of the dissolved hydrogen concentration DH of various sample waters.
- the semiconductor substrate cleaning system 100 is, for example, a method for partially cleaning the surface of a semiconductor substrate coated with an oxide film. This is a step of surface-treating the exposed bare pattern using a cleaning solution such as pure water, a mixed solution of acid and pure water, and a mixed solution of alkaline and pure water. In this method, hydrogen-dissolved water, especially reduction potential water is used.
- the antioxidant target according to the present invention is a semiconductor substrate, and ultraviolet rays described below are used as the catalyst according to the present invention.
- the cleaning system includes a pure water generator 13, a reduction potential water generator 11, and a treatment tank 16, and the pure water 14 generated by the pure water generator 13 is It is supplied to the inlet port 111 of the reduction potential water generator 11, where it is electrolyzed by applying a voltage to the electrode plates 116, 117 to become reduction potential water 15. Then, the thus obtained reduction potential water 15 is introduced into the processing tank 16 into which the semiconductor substrate (wafer) W is charged. In the processing tank 16, the wafer W is held in a wafer case 17, and a sealable lid 18 is provided in the processing tank 16 to prevent dust, oxygen, carbon dioxide, etc. from entering from the atmosphere. To prevent it.
- an ultraviolet lamp 19 is provided in the treatment tank 16, and by irradiating UV during cleaning with the above-mentioned reduction potential water 15 by the above-described reduction potential water 15, a catalytic action on the reduction potential water is performed.
- the reducing potential water obtained by the reducing potential water generator 11 of the present example exerts a reducing power only when necessary, and has no operational effect when unnecessary.
- the reduction potential water is just ordinary water obtained by electrolysis of raw ice. Therefore, even after exerting the reducing power, it only behaves as normal water and does not have any adverse effect on the surface of the silicon substrate to be cleaned. Furthermore, its reduction Since the action suppresses the generation of silicon oxide, the same cleaning effect as that obtained by the conventional treatment with a mixed liquid of various kinds of acid-alkali water can be expected without producing water glass. It is also possible to reduce the amount of chemical used compared to the conventional method. From this viewpoint, it is possible to ensure process safety, reduce the amount of chemicals used, and simplify the process.
- reference numeral 20 denotes a hydrofluoric acid container.
- the valve 21 is opened, and the hydrofluoric acid solution in the hydrofluoric acid container 20 is arbitrarily added to the reducing potential water 15 so that the silicon wafer W The oxide film can be removed.
- reference numeral 22 denotes a gas-liquid separation device, which can remove unnecessary gas mixed in the reducing potential water through the valve 23.
- the reduction potential water generator 11 of the present example has an inlet 1 1 1 for introducing raw water such as pure water and an outlet 1 1 2 for taking out the generated reduction potential water.
- An electrolytic chamber 113 is formed between the inlet 111 and the outlet 112.
- the inlet 111 is provided at the bottom of the casing 114 so that the raw water is introduced in a direction perpendicular to the drawing paper.
- An outlet 112 is formed on the top surface of the casing 114 so that the electrolytic water is taken in a direction perpendicular to the plane of the drawing.
- porous membranes 115 are provided on the left and right side walls of the reduction potential water generator 11, respectively, and are provided in a state where the electrode plate 116 is in contact with the outside of the membrane 115. Have been.
- the other electrode plate 17 is provided in the electrolysis chamber 113 such that its main surface faces the one electrode plate 116 respectively.
- a DC power supply 12 is connected to these two pairs of electrode plates 1 16, 1 17, and an anode is connected to one of the pair of electrode plates 1 16, 1 17 facing each other across the diaphragm 115.
- the cathode is applied to the other electrode plate.
- the cathode of the DC power supply is connected to the electrode plate 117 provided in the electrolysis chamber 113.
- the anode is connected to an electrode plate 116 provided outside the electrolytic chamber 113.
- the anode of a DC power supply is connected to the electrode plate 117 provided in the electrolysis chamber 113, and is provided outside the electrolysis chamber 113.
- the cathode may be connected to the electrode plate 116.
- the diaphragm 115 used in the present example has such a property that water flowing into the electrolysis chamber 113 easily permeates, and that the water that penetrates does not drip easily. That is, in the reduction potential water generator 11 of the present example, a water film is formed in the diaphragm 115 itself and a small gap S between the diaphragm 115 and the electrode plate 116 during electrolysis, and the water film is formed through the water film. Current flows through both electrode plates 1 16 and 1 17. Therefore, it is important that the water constituting the water film is sequentially replaced in order to increase the electrolysis efficiency.
- the aggregate is polyester non-woven fabric or polyethylene screen
- the membrane material is chlorinated titanium or polyvinylidene fluoride and titanium oxide or polyvinyl chloride
- the thickness is 0.1 to 0. 3mm, average pore size 0.
- Examples thereof include a porous membrane having a water permeability of not more than 1.0 to 1.0 m and a water permeability of 1. Occ / cm ⁇ min, or a solid electrolyte membrane.
- a cation exchange membrane is used as the membrane 115, a cation exchange group perfluorosulfonic acid membrane whose base material is polytetrafluoroethylene, such as a Nafion membrane manufactured by Du Pont, is used.
- a copolymer of cation exchange group vinyl ether and tetrafluoroethylene, such as Flemion membrane manufactured by Asahi Kasei can be used.
- the distance between the boards is Omn! 5.5.0 mm, more preferably 1.5 mm.
- the distance between the electrode plates 1 16 and 117 is 0 mm, for example, when a zero-gap electrode on which electrode films are directly formed on both main surfaces of the diaphragm 115 is used, Has a distance corresponding to the thickness of the diaphragm 115.
- Zero gear gap The electrode may be formed on only one main surface of the diaphragm 115. When such a zero gap electrode is used, holes or gaps for allowing gas generated from the electrode surface to escape to the back side opposite to the diaphragm 115 are provided in the electrode plates 1 16 and 117. It is desirable. Note that the configuration in which holes or gaps are provided in the electrode plates 116 and 117 can be adopted also in the electrode plate provided in the electrolytic cell shown in FIG.
- the distance between the electrode plates 117 and 117 provided in the electrolysis chamber 113 is not particularly limited, but is 0.5 mm to 5 mm, more preferably 1 mm.
- a direct current is applied to two electrode plates 117, 117 provided in the electrolysis chamber 113.
- the negative electrode (1) of the power supply 12 is connected, and the positive electrode (+) of the DC power supply 12 is connected to the electrode plates 116, 116 provided outside the electrolytic chamber 113, and the diaphragm 115 is sandwiched therebetween.
- a voltage is applied to two pairs of electrode plates 116 and 117 facing each other. Then, when pure water or the like is introduced from the inlet 1 11, water electrolysis is performed in the electrolytic chamber 113, and the surface of the electrode plate 117 and the vicinity thereof are
- the H ions pass therethrough while being contained in the diaphragm 115, and a part of the H ions receive electrons e from the cathode plate 117, become hydrogen gas, and dissolve into the electrolyzed water on the cathode side.
- the electrolyzed water generated on the cathode side (that is, in the electrolysis chamber 113) has a higher oxidation-reduction potential than the electrolyzed water generated using the conventional diaphragm electrolysis technology.
- the reduction potential water obtained by such electrolytic treatment is desired to have a desired pH value
- a solution of a pH buffering salt such as phthalate, phosphate, borate or the like is used.
- the pH value of raw water may be adjusted. This is because the reduction potential water generator 11 does not greatly change the pH of the raw water. Specifically, for example, if it is desired to tilt the pH to alkaline for the purpose of cleaning silicon substrates or for beverages, the pH value of the raw water may be controlled and adjusted to a value close to the total strength. If you want to make the pH almost neutral for beverages, injections, infusions, or dialysates, you can adjust the pH of the raw water to near neutrality, and use it for cosmetics. If it is desired to make the pH weakly acidic in order to reduce the pH, the pH of the raw water may be controlled and adjusted to a value near weak acidity.
- the apparatus shown in FIG. 5 has been described as an apparatus for generating reduction potential water, but this apparatus 11 can also be applied to the case of generating oxidation potential water.
- the anode (+) of the DC power supply 12 is connected to the two electrode plates 1 17, 1 17 provided in the electrolysis chamber 113, and provided outside the electrolysis chamber 113.
- the negative electrode (1) of the DC power supply 12 is connected to the electrode plates 1 16 and 1 16 and the voltage is applied to the two pairs of electrode plates 1 16 and 1 17 that face each other across the diaphragm 115. May be applied.
- pure water or the like is introduced from the inlet port 111, water is electrolyzed in the electrolytic chamber 113, and on the surface of the electrode plate 117 and in the vicinity thereof,
- Electrolyzed water has a higher oxidation-reduction potential than electrolyzed water generated using conventional diaphragm electrolysis technology.
- the residual OH ions that have passed through the diaphragm 115 react with the H ions in the electrolysis chamber 113 and return to water, so that the pH of the oxidation potential water generated in the electrolysis chamber 113 becomes slightly neutral. Will be. In other words, it is possible to obtain an oxidation potential water whose pH is not so low but whose ORP is high. Oxidation potential water containing hydrogen ions thus generated is supplied from the outlet 112.
- the cathode (1) of the DC power supply 12 was connected to the two electrode plates 117, 117 provided in the electrolysis chamber 113 using the reduction potential water generator 11 shown in FIG.
- the anode (+) of the DC power supply 12 is connected to the electrode plates 116 and 116 provided outside the electrolytic chamber 113 (the effective area of the electrode plate is 1 dm 2 ), and the pH is 7.9, OR
- Electrolysis was carried out in a continuous flow-through type at a flow rate of 1 liter per minute at a flow rate of 1 liter per minute from Fujisawa ⁇ tap water with a P of +473 mV.
- a Nafion membrane manufactured by Du Bonn which is a positive ion exchange membrane, was used as the diaphragm 115, the distance between the electrode plates 116, 117 was 1.2 mm, and the electrode plates in the electrolysis chamber 113 were used. The distance between 117 and 117 was 1.4 mm.
- pH 9.03
- H ions generated in the vicinity of the water film between the anode plate 11 and the anode plate 11 pass through the diaphragm 115 to the electrolysis chamber 113, and then to the OH ions in the electrolysis chamber 113.
- the neutralization reaction returns to the original water after the sum reaction, and this neutralization reaction takes place over time until the concentration chemical equilibrium is established even when the reduced potential water after the electrolytic treatment is allowed to stand still. It is considered that the promotion is the cause.
- the reduction activity evaluation test the antioxidation subject and to methylene blue (tetramethylthionine chloride;. C 16 H 18 C1N3S 3 (3 ⁇ 40)) while there use a radical scavenging activity
- the DPPH radical (1, l-diphenyl-2-picrrylhydrazyl), which is a relatively stable radical in aqueous solution, is used as an antioxidant target.
- methylene blue which belongs to the category of redox dyes, as an antioxidant target
- Oxidized methylene pull aqueous solution (maximum absorption wavelength: about 665 nm; hereinafter, methylene blue ) Is blue, but when it is reduced to reduced methylene blue (mouth methylene blue), the color changes from blue to colorless.
- the degree of this blue disappearance is used to evaluate the reducing activity, that is, the reducing power.
- the reduced methylene blue has a low solubility, so a white precipitate is formed, but when reoxidized, it becomes the original oxidized methylene blue and returns to blue. That is, the color reaction of the aqueous solution of methylene blue is reversible.
- DPPH radical aqueous solution (maximum absorption wavelength: about 500 ⁇ m; hereinafter, sometimes referred to as “DPPH”).
- DPPH maximum absorption wavelength: about 500 ⁇ m; hereinafter, sometimes referred to as “DPPH”.
- DPPH maximum absorption wavelength
- has a deep red color and when such DPPH is reduced and no longer a radical, the deep red color fades.
- the degree of this fading is used to evaluate the radical scavenging activity, that is, the antioxidant power.
- the color reaction of the aqueous solution of DPPH radical is irreversible.
- the explanation of the evaluation test is as follows: (1) Evaluation of reduction activity of electrolyzed water added with P-7 colloid catalyst by color change of methylene blue; (2) P-7 colloid ZP d colloid catalyst added by hydrogen change by color change of methylene blue Evaluation of reduction activity of dissolved water (degassing + hydrogen gas filling), (3) Pt colloid catalyst based on color change of methylene blue Evaluation of reduction activity of added electrolyzed water (added before electrolysis / added after electrolysis), (4) Evaluation of antioxidant activity of Pt colloid catalyst-added electrolyzed water by color change of D PPH radical, (5) Evaluation of the antioxidant activity of the catalyst-added hydrogen-dissolved water (degassing treatment + hydrogen gas filling treatment) based on the color change of DPPH radicals shall be performed in the following order.
- Aqueous solution containing Pt colloid obtained by adding 6 mL of P7 standard solution to 1494 mL of basic water (6.86)
- the methylene pull-absorbance (A589) of the aqueous solution obtained by adding methylene pull to the catalyst-free aqueous solution, which is the basic water 6, 86 of sample i, is referred to as Reference Example 1.
- the results are shown in FIG.
- the methylene blue absorbance (A589) of an aqueous solution obtained by adding methylene pull to a catalyst-free aqueous solution, which is 9.18, the basic water of Sample V, is referred to as Reference Example 4, and the results are shown in FIG.
- the methylene blue absorbance (A589) of the aqueous solution obtained by adding methylene to the aqueous solution containing the catalyst, which is (basic water 9.18 + Pt standard solution) of sample vi, is referred to as Reference Example 5, and the results are shown in FIG.
- FIG. 7 shows a comparison with Examples 4 to 6.
- Example 3 Methylene pull-absorbance change of aqueous solution obtained by adding Pt standard solution to Pt colloid concentration to 190 ⁇ g / L to hydrogen-dissolved water with MB (basic water with MB 7.4 + degassing + hydrogen gas filling treatment) ( ⁇ 572) as Example 3, and the results are shown in FIGS. 8 and 9, respectively.
- Example 4 Change in methylene blue absorbance of an aqueous solution obtained by adding a Pt standard solution to an amount of 190 ⁇ g of Pt colloid to a hydrogen-dissolved water containing MB (basic water containing MB 9.0 + degassing treatment + hydrogen gas filling treatment) ⁇ 572) as Example 4, and the results are shown in FIG. 8 in comparison with Example 3.
- the difference between the sample waters of Example 3 and Example 4 is the pH.
- the methylene blue-absorbance change ( ⁇ 572) of an aqueous solution obtained by adding a Pd standard solution to a hydrogen-dissolved water containing MB (basic water containing MB 7.4 + degassing treatment + hydrogen gas filling treatment) in an amount such that the palladium colloid concentration becomes 444 gZL was measured.
- Example 6 is shown in FIGS. 10 and 11, respectively.
- Example 8 Change in the methylene blue absorbance of an aqueous solution obtained by adding a Pd standard solution to a hydrogen-dissolved water containing MB (basic water containing MB 7.4 + degassing treatment + hydrogen gas filling treatment) so that the palladium colloid concentration becomes 11 l / g / L ( ⁇ 572) as Example 8, and the results are shown in FIG. 11 in comparison with Example 6.
- the difference between the sample waters of Example 6 and Example 8 is the palladium colloid concentration.
- a mixed solution with a molar ratio of Pt standard solution to Pd standard solution of about 1 mixed with precious metal is mixed with hydrogen-containing hydrogen-dissolved water (basic water containing MB 7.4 + degassing + hydrogen gas filling) (Pt + Example 9
- the change in methylene blue absorbance ( ⁇ ⁇ 572) of the aqueous solution to which the colloid concentration was 160 g / L was set as Example 9, and the results are shown in FIGS. 12 and 13, respectively.
- Example 10 shows the change in absorbance of methylene blue ( ⁇ A 572) of the aqueous solution added by an amount corresponding to / L, and the results are shown in FIG. 12 in comparison with Example 9.
- the difference between the sample waters of Example 9 and Example 10 is pH.
- Example 9 The same mixed solution as in Example 9 was mixed with hydrogen-containing hydrogen-dissolved water (basic water containing MB 7.4 + degassing + hydrogen gas filling) in such an amount that the precious metal mixture (Pt + Pd) colloid concentration became 80 g / L.
- the change in absorbance of methylene blue ( ⁇ 572) of the aqueous solution to which only the above was added was taken as Example 11, and the results are shown in FIG. 13 in comparison with Example 9.
- the difference between the sample waters of Example 6 and Example 8 is the noble metal (Pt + Pd) colloid concentration.
- FIG. 8 which compares Examples 3 and 4, shows the MB reduction activity of Pt colloid-added hydrogen-dissolved water at pH 7.4 and pH 9.0. According to the figure, there is no significant difference in MB reduction activity due to the difference in pH, and both show high MB reduction activity.
- FIG. 10 which compares Examples 6 and 7, shows the MB reduction activity of Pd colloid-added hydrogen-dissolved water at pH 7.4 and pH 9.0. According to the figure, there is no significant difference in MB reduction activity due to the difference in pH, and both show high MB reduction activity.
- FIG. 11 which compares Examples 6 and 8, shows the MB reduction activity of Pd colloid-added hydrogen-dissolved water at Pd colloid concentrations of 111 ⁇ g ZL and 444 ⁇ g / L. According to the figure, the higher the Pd colloid concentration, the higher the MB reduction activity. Therefore, it is considered effective to increase the Pd colloid concentration in order to increase MB reduction activity.
- FIG. 12 which compares Examples 9 and 10, shows the MB reduction activity of precious metal mixed (Pt + Pd) colloid-added hydrogen-dissolved water at pH 7.4 and pH 9.0. According to the figure, there is no significant difference in MB reduction activity due to the difference in pH, and both show high MB reduction activity.
- Figure 13 comparing Examples 9 and 11 shows the precious metal mixed (Pt + Pd) colloid concentration of 8 O ⁇ g / L and the precious metal mixed (Pt + Pd) colloid-added hydrogen-dissolved water at 160 gZL. Shows MB reduction activity. According to the figure, the higher the precious metal mixed (Pt + Pd) colloid concentration, the higher the MB reduction activity. This suggests that increasing the precious metal mixed (Pt + Pd) colloid concentration is effective in increasing MB reduction activity.
- Fig. 8 (Examples 3 and 4; MB reduction activity of Pt colloid-added hydrogen-dissolved water) and Fig. 10 (Examples 6 and 7; Pd colloid-added hydrogen-dissolved water of MB-reduced activity) It can be seen that Examples 3 and 4 show the same MB reduction activity as Examples 6 and 7, even though the concentration is lower. In addition, the molar concentration (M) of both is compared. Even so, Pt colloid is 0.98 / M, whereas Pd colloid is 4.17M, which is lower for Pt colloid.
- the Pt colloid is more effective than the Pd colloid in the sense that the amount used to obtain the same MB reduction activity can be reduced. It can be said that it is excellent.
- Pt colloid solution 48 mg / L Pt colloid solution was added to the cell without P colloid. While adding 2 L, add 0.14 mL of a 1 g ZL-concentrated aqueous solution of methylene bleed that has been degassed and filled with hydrogen gas to the cell containing the Pt colloid, and measure both cell solutions with a spectrophotometer. To start. The concentration of P-7 colloid added to both cells was adjusted to about 182 g / L.
- Example 13 The minimum value of the methylene blue absorbance (A 572) of the electrolyzed water added after the catalyst (basic water containing MB and added after 6.86 + Pt colloid electrolysis) up to 30 minutes after the start of the measurement is Example 13, and the results are shown in Example 13.
- FIG. 14 shows a comparison with Example 12.
- FIG. 14 which compares Examples 12 and 13, shows the MB reduction activity of the electrolyzed water when the addition time of the P7 colloid (before or after the electrolysis) is changed.
- the activated hydrogen which is the source of MB reduction activity, invalidates the oxidizing power of oxidizing substances such as oxygen in the electrolyzed water. Is done. This is because when the dissolved oxygen concentration of the electrolyzed water treated with the activated carbon treated water containing Pt colloid as raw water was measured immediately after the electrolysis treatment, the dissolved oxygen concentration of the electrolyzed water was almost zero.
- the pre-treatment addition of the catalyst obtains a higher MB reduction activity (the oxidizing substance such as oxygen has It is considered to be preferable from the viewpoint.
- the catalyst is not limited to Pt colloid, but Pd colloid or a mixed colloid of P7 colloid and Pd colloid is also added to the catalyst before treatment from the viewpoint of obtaining higher MB reduction activity. preferable.
- each of the eight sample aqueous solutions for samples i to vSi shown in Table 2 was used to examine its antioxidant activity.
- the DPPH absorbance difference ( ⁇ 540) of the aqueous solution obtained by adding DPPH to the catalyst-free aqueous solution, which is 6.86, which is the basic water of Sample i, is referred to as Reference Example 7, and the results are shown in FIG.
- the change in DPPH absorbance ( ⁇ 540) in the figure indicates the difference ( ⁇ 540) between the absorbance of this sample i (blank) and the absorbance of samples i to iv. Therefore, the change in the DPPH absorbance ( ⁇ 540) of Reference Example 7 is zero. (Reference Example 8)
- Reference Example 8 shows the change in DPPH absorbance ( ⁇ ⁇ 540) of the aqueous solution obtained by adding DPPH to the aqueous solution containing the catalyst, which is the sample ⁇ (basic water 6.86 + ⁇ t standard solution), and the results are shown in Figure 15.
- Example 14 shows the change in DPPH absorbance ( ⁇ 540) of the aqueous solution obtained by adding DPPH to the catalyst-treated electrolyzed water, which is (basic water 6.86 + electrolysis + Pt standard solution) of sample iv, as Example 14.
- FIG. 15 shows a comparison with Examples 7 to 9.
- the DP ⁇ absorbance change ( ⁇ 540) of an aqueous solution obtained by adding D ⁇ ⁇ to the electrolyzed water without catalyst, which is (basic water 9.18 + electrolysis treatment) of sample ⁇ , is referred to as Reference Example 12, and the results are shown in Fig. 16. .
- Example 15 shows the change in DPPH absorbance ( ⁇ A 540) of the aqueous solution obtained by adding DPPH to the catalyst-treated electrolyzed water (basic water 9.18 + electrolysis + Pt standard solution) in the sample.
- FIG. 16 shows a comparison with Examples 10 to 12.
- Reference Example 13 shows the change in DPPH absorbance ( ⁇ 540) of an aqueous solution in which the Pt standard solution was not added to the hydrogen-dissolved water (basic water 7.4 + degassing treatment + hydrogen gas filling treatment), and the results are shown in Figure 17.
- FIG. 17 which compares Reference Example 13 with Example 16, shows the D P P H radical scavenging activity of hydrogen-dissolved water at P H 7.4 with the difference between the presence and absence of Pt colloid.
- the absorbance change was observed by the amount considered to have been spontaneously bleached within the measurement time (30 minutes), while the example with Pt colloid was observed.
- a clear DPPH radical scavenging activity exceeding the amount of spontaneous bleaching was observed. It should be noted that there was no difference in the level of DP PH radical scavenging activity due to the difference in pH.
- Methylene blue absorbance change ( ⁇ ⁇ A 572) of the aqueous solution without hydrogenase solution added to the hydrogen-dissolved water with MB (basic water with MB 9.0 + degassing + hydrogen gas filling) 20 is shown in FIG. 20 in comparison with Example 19.
- the difference between the sample waters of Example 19 and Reference Example 16 is the presence or absence of the enzyme hydrogenase.
- Hydrogen generated by the cathodic reaction during the electrolytic treatment is certainly dissolved in the electrolytically treated water (electrolytically reduced water) electrolytically treated by the reduction potential water generator 11 developed by the present applicant.
- the concentration of hydrogen dissolved in the electrolyzed water can be temporarily measured using a dissolved hydrogen meter.
- the reason for this is that the dissolved hydrogen meter generally adopts the measurement principle of replacing the electrochemical physical quantity in the electrode reaction with the dissolved hydrogen concentration by the staple look-up method. Liquid This is because the measured value tends to fluctuate relatively largely depending on which external factor.
- an oxidized methylene blue or other oxidized reducing dye (to be subjected to antioxidation) may be added.
- the dye did not show a color change specific to the reduction reaction, whereas the dye showed a color change specific to the reduction reaction in the catalyst-added electrolyzed water obtained by adding a catalyst to the electrolyzed water.
- the oxidation-reduction reaction of the oxidation-reduction dye was visually recognized by observing the color change of the (catalyst-added electrolyzed water + oxidation-reduction dye) solution.
- the inventors of the present invention have conducted intensive studies on the industrial applicability of this correlation, and found that the redox reaction of the redox dye methylene blue enables the apparent antioxidant power of the catalyst-added electrolyzed water to be reduced. He came up with the idea that (dissolved hydrogen concentration) could be quantitatively analyzed.
- the chemical contained in the hydrogen-dissolved water In order to quantitatively analyze the effective amount of reducing power (antioxidant power) generated by the activation of chemically inert molecular hydrogen, that is, the effective dissolved hydrogen concentration DH (mg / L), Using Pt colloid as a catalyst and methylene blue as a redox dye, redox titration of methylene blue with hydrogen dissolved in catalyst (Pt colloid) was performed.
- a solution injection section consisting of a cylindrical hollow tube made of acryl is provided outward in the radial direction of the tester so that it can be injected.
- a rubber stopper for inserting a syringe 21 dollars is detachably provided in the solution injection section.
- test device When pouring a 40-fold concentration Pt standard solution or MB solution into the test water storage chamber of the tester, the solution was sucked and collected so as not to generate a gas phase in the syringe. Insert a dollar into the rubber stopper attached to the solution injection section, and then gently inject the solution by pressing the syringe piston.
- the test device disclosed here is only an example, and that the material is gas-impermeable, that the test water storage room can be isolated from the external environment, and that the volume of the test water storage room is variable. That the test water storage chamber can be kept air-tight and liquid-tight, and that the 40-fold concentration Pt standard solution and MB solution can be charged while the test water storage chamber is isolated from the external environment. If other conditions such as that the stirrer for the stirrer is operable, etc. can do.
- the tester containing the test water is placed on a magnetic stirrer table with its bottom face down, and stirring with a stirrer is started.
- the above-mentioned aqueous solution of methylene bull with a predetermined concentration in which the nitrogen gas has been replaced is injected in small quantities using a syringe while visually observing the color change of the test water.
- the dissolved hydrogen concentration of the test water is higher than the input amount of methylene blue, the methylene blue is reduced and becomes colorless, but if the input amount of the aqueous methylene blue solution is gradually increased, the added methylene blue is added. And the dissolved hydrogen in the test water cancel each other out, and the color change of methylene blue from blue to colorless can no longer be observed.
- the dissolved hydrogen concentration DH of the test water can be obtained from the methylene blue concentration of the methylene blue aqueous solution and the total amount of the added methylene pull aqueous solution.
- the volume of the test water was set to 20 OmL, and the molar concentration of methylene blue in the aqueous methylene blue solution to be added to the test water was set to ⁇ ( ⁇ 6 ⁇ 1 / cc). Assuming that the total amount of methylene blue aqueous solution is A (mL), the total amount of added methylene blue molecule B (mo 1) is
- reaction formula 1 H 2 + MBC 1 ⁇ HC 1 + MBH
- reaction formula 1 HC 1 is hydrochloric acid
- MBH reduced methylene chloride
- reaction formula 1 1 mol of hydrogen molecule and 1 mol of methylene ble react with each other to produce 1 mol of reduced methylene blue molecule.
- reaction equation is divided into two equations by a semi-reaction equation and written as follows.
- Half-reaction 1 means that one mole of hydrogen molecule emits 2 moles of electrons, while half-reaction 2 , One mole of methylene blue cation, meaning one mole of methylene blue molecule receives 2 moles of electrons, where 1 mole of hydrogen molecule emits 2 moles of electrons, which is equivalent to 2 gram equivalent, One mole of methylene cation, or one mole of methylene ble, receives two moles of electrons and is equivalent to two gram equivalents, resulting in the hydrogen molecule and one molecule of methylene ble cation, one molecule of methylene pulp.
- the volume of the test water is 20 OmL
- the effective molar concentration of hydrogen molecules H 2 (mo 1 / L) of the test water is expressed as the number of moles C (mo 1) in volume (mL). Since it is a divided value,
- the effective mass concentration D of hydrogen molecules is on the order of micrograms. To convert them to the order of milligrams, multiply the numerator and denominator by 1000.
- Equation 6 the number of moles C of hydrogen molecules in Equation 6 can be replaced by the total amount B of methylene bleed
- the methylene blue reduced by the activation of molecular hydrogen remains colorless as reduced methylene blue or exists as a white precipitate. Even if such oxygen molecules coexist, the reduced methylene blue is oxidized again to return to the original oxidized methylene pull. Also, even without the intervention of methylene blue, the activated hydrogen molecules directly react with oxygen molecules, etc., depriving a considerable amount of hydrogen molecules of reducing power. You will not be able to. In other words, for example, as shown in FIGS. 21 and 22, when oxides such as oxygen molecules coexist in the hydrogen-dissolved water, the amount of hydrogen molecules corresponding to these amounts is consumed and added to the equivalent point. The total amount of methylene blue produced will also decrease with the amount of oxide.
- the dissolved hydrogen concentration measured by the quantitative analysis method using methylene blue is the effective dissolved hydrogen concentration obtained by subtracting the hydrogen concentration consumed by the oxidizing agent such as dissolved oxygen. It can be said that there is. .
- the total injection volume of the same aqueous solution of methylene blue up to the equivalent point was 6.2 mL, and the actual measured value of the dissolved hydrogen concentration DH obtained by substituting each value into the above equation ⁇ was 1.66 (mg / L).
- Table 3 shows the physical properties of the test water according to Reference Example 19, and Fig. 23 shows the measured and effective values of the dissolved hydrogen concentration DH.
- Electrolyzed water obtained by electrolyzing 6.86 basic water at a flow rate of 1 liter per minute at a flow rate of 1 liter per minute into continuous water under electrolysis conditions of 5 A was used as the test water.
- 10 g / L concentration to the test! K A methylene blue aqueous solution (volume concentration: 267737.8 / M) was injected in small quantities using a syringe while visually observing the color change of the test water.
- the total injection volume of the same aqueous solution of methylene butyl up to the equivalent point is 5.9 mL, and the measured value of the dissolved hydrogen concentration DH obtained by substituting each value into Equation 7 above is 1.58 (mg / L) Met.
- Table 3 shows various physical property values of the test water according to Example 20, and FIG. 23 shows the measured and effective values of the dissolved hydrogen concentration DH.
- the test water was obtained by electrolyzing the basic water of Sample V 9.18 described above at a flow rate of 1 liter per minute at a constant current of 5 A and electrolyzing continuously in a continuous water system. Then, lmL of the above 40-fold concentration of the nitrogen gas-substituted P-seven standard solution was injected into the test water storage chamber using a syringe, thoroughly stirred and mixed, and then a 10 g / L concentration was added to the test water. (Molar molarity: 26773.8 / M) was injected with a small amount of syringe while visually observing the color change of the test water.
- the total injection volume of the same aqueous solution of methylene butyl up to the equivalent point is 5.OmL
- the measured value of the dissolved hydrogen concentration DH obtained by substituting each value into the above equation 7 is 1.34 (mg / L) Met.
- Table 3 shows various physical property values of the test water according to Example 21 and FIG. 23 shows actual measured values and effective values of the dissolved hydrogen concentration DH.
- the water to be electrolyzed in a continuous water flow method was used as the test water, and 1 mL of the 40-fold concentrated P7 standard solution, which had been purged with nitrogen gas, was added to 20 mL of the test water using a syringe. After pouring the mixture into the test water storage chamber and mixing well, mix the test water with 10 g ZL concentration (molarity; 2 677 3.8 ⁇ ) of methylene bull solution and color the test water.
- the above-mentioned basic water 6.86 of sample i was electrolyzed for 3 minutes in a continuous water circulation system (circulating water volume: 0.8 liters) at a flow rate of 1 liter per minute and electrolysis conditions of 5 A constant current.
- a continuous water circulation system circulating water volume: 0.8 liters
- electrolysis conditions 5 A constant current.
- 1 mL of the 40-fold concentration Pt standard solution with the above-mentioned nitrogen gas replaced with 20 OmL of the test water was injected into the test water storage chamber using a syringe.
- 10 g / L aqueous solution of methylene pull volume concentration: 267 73.8 ⁇
- the electrolytically treated water was used as the test water, and 1 mL of the 40-fold concentration Pt standard solution with the above-mentioned nitrogen gas replaced by 20 mL of the test water was injected into the test water storage chamber using a syringe.
- a circulating electrolysis treatment in which the same pH buffer aqueous solution as in Example 22 was electrolyzed at a flow rate of 1 liter per minute under a 5 A constant current electrolysis condition in a continuous water circulation type (circulating water volume: 0.8 liter) for 3 minutes.
- a continuous water circulation type circulating water volume: 0.8 liter
- 20 mL of the test water 1 mL of the above-mentioned 40-fold concentration Pt standard solution with nitrogen gas replacement, is injected into the test water storage chamber using a syringe, and thoroughly stirred and mixed.
- the actual value of the dissolved hydrogen concentration DH and the effective value have a corresponding correlation since the effective value increases as the actual value increases.
- the effective value of the dissolved hydrogen concentration DH of Reference Example 18 and Examples 20 to 25 was higher than the effective DH value of Reference Example 17 in all cases, exceeding 1.3 (mg / L).
- the concentration was indicated.
- the effective DH value of Examples 20 to 25 is such that the saturated dissolved concentration of molecular hydrogen in water at normal temperature (20 ° C.) and atmospheric pressure is approximately 1.6 (mg / L). In contrast, the concentration was extremely high, about 2.5 to 3.3 (mg / L).
- the antioxidant method proposed in the present invention is applied, as in the reduction potential water generation device developed by the present applicant, while the dissolved hydrogen concentration is increased as much as possible, the oxidation of dissolved oxygen and the like is performed. It is important to keep the substance concentration as low as possible in order to achieve the reduction activity and antioxidant activity derived from the antioxidant functional water relating to the combination of the hydrogen-dissolved water and the catalyst according to the present invention.
- the dissolved hydrogen water according to the present invention is defined from the viewpoint of the effective value of the dissolved hydrogen concentration DH obtained by using the dissolved hydrogen concentration determination method using the redox dye according to the present invention.
- a dissolved hydrogen water one having a DH effective value of 1.3 or more is preferable, and furthermore, 1.4 or more, 1.5 or more, 1.6 or more, 1.7 or more, 1.8 or more, 1. 9 or more, 2.0 or more, 2.1 or more, 2.2 or more, 2.3 or more,
- the outline of the present invention exemplifies that a hydrogen oxidoreductase, a hydrogenase, or a noble metal colloid is allowed to act on a reduction potential water on a living cell as an antioxidant target
- a hydrogen oxidoreductase, a hydrogenase, or a noble metal colloid is allowed to act on a reduction potential water on a living cell as an antioxidant target
- ultraviolet rays act on the reduction potential water on, for example, a silicon substrate as an antioxidant target
- the present invention is not limited to such an embodiment.
- electromagnetic waves containing ultraviolet rays are applied to the reducing potential water, or electromagnetic waves containing ultraviolet rays, and hydrogen oxidoreductase, hydrogenase, or It is also possible to combine precious metal colloid with, and to react hydrogen oxidoreductase, hydrogenase, or precious metal colloid on reducing potential water, for example, on a silicon substrate as an antioxidant target. Alternatively, it is also possible to act on the reduction potential water by combining hydrogen oxidoreductase, hydrogenase, or a noble metal colloid with electromagnetic waves including ultraviolet rays. Of course.
- methylene blue has been exemplified as the redox dye.
- the redox dye is not limited to this example.
- new methylene blue, neutral Blades, indigo carmine, acid blades, safranin ⁇ , phenosafuranine, capriblue, nile bull, diphenylamine, xylenesanol, nitrodiphenylamine, phenoin, polyphenylanthranilic acid, etc. are preferred. Can be used.
- a hydrogen re-pressure treatment method which is a modified example in which the antioxidant method according to the present invention is applied to, for example, treatment of a disease of a patient.
- a catalyst solution according to the present invention such as a Pt colloid solution
- the pressure inside the recompression chamber is gradually increased while observing the patient indoors or outdoors. Go.
- the gas supplied into the recompression chamber is adjusted so that hydrogen occupies about 1 to 20% of the compositional component partial pressure ratio.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Environmental & Geological Engineering (AREA)
- Hydrology & Water Resources (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Electrochemistry (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Removal Of Specific Substances (AREA)
- Treatment Of Water By Oxidation Or Reduction (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Water Treatment By Electricity Or Magnetism (AREA)
Description
Claims
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/480,265 US20040154993A1 (en) | 2001-06-29 | 2002-06-28 | Method for antioxidation and antioxidative functional water |
EP02741360A EP1413555A4 (en) | 2001-06-29 | 2002-06-28 | ANTIOXIDATION PROCESS AND ANTIOXIDANT WATER |
BR0210726-0A BR0210726A (pt) | 2001-06-29 | 2002-06-28 | Método de anti-oxidação e água que funciona como anti-oxidante |
CA002452682A CA2452682A1 (en) | 2001-06-29 | 2002-06-28 | Method for antioxidation and antioxidative functional water |
MXPA03011983A MXPA03011983A (es) | 2001-06-29 | 2002-06-28 | Metodo de antioxidacion y agua que funcionada como antioxidante. |
KR1020037017108A KR100726057B1 (ko) | 2001-06-29 | 2002-06-28 | 항산화방법 및 항산화 기능수 |
JP2003508656A JP4272054B2 (ja) | 2001-06-29 | 2002-06-28 | 抗酸化方法、および抗酸化機能水 |
TW091137152A TWI270532B (en) | 2002-02-08 | 2002-12-24 | Method for antioxidation and antioxidative functional water |
JP2004548012A JP4511361B2 (ja) | 2002-04-26 | 2003-04-25 | 被検定水の溶存水素濃度の定量分析方法及び装置 |
EP03719221A EP1550637A1 (en) | 2002-04-26 | 2003-04-25 | Method of inhibiting oxidation, water capable of inhibiting oxidation and use thereof |
US10/512,382 US20050170011A1 (en) | 2002-04-26 | 2003-04-25 | Method of inhibiting oxidation, water capable of inhibiting oxidation and use thereof |
AU2003235942A AU2003235942A1 (en) | 2002-04-26 | 2003-04-25 | Method of inhibiting oxidation, water capable of inhibiting oxidation and use thereof |
PCT/JP2003/005386 WO2004039735A1 (ja) | 2002-04-26 | 2003-04-25 | 抗酸化方法、抗酸化機能水およびその用途 |
US12/397,960 US20090181105A1 (en) | 2002-04-26 | 2009-03-04 | Method of antioxidation, antioxidant-functioning water, and usage of the same |
JP2009272133A JP2010051963A (ja) | 2002-04-26 | 2009-11-30 | 高濃度水素溶存水を含有する飲料 |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001200001 | 2001-06-29 | ||
JP2001-200001 | 2001-06-29 | ||
JP2002032845 | 2002-02-08 | ||
JP2002-32845 | 2002-02-08 | ||
JP2002-125986 | 2002-04-26 | ||
JP2002125986 | 2002-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003002466A1 true WO2003002466A1 (fr) | 2003-01-09 |
Family
ID=27347062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/006560 WO2003002466A1 (fr) | 2001-06-29 | 2002-06-28 | Procede d'antioxydation et eau a fonction antioxydante |
Country Status (9)
Country | Link |
---|---|
US (2) | US20040154993A1 (ja) |
EP (1) | EP1413555A4 (ja) |
JP (1) | JP4272054B2 (ja) |
KR (2) | KR100726057B1 (ja) |
CN (1) | CN1296290C (ja) |
BR (1) | BR0210726A (ja) |
CA (1) | CA2452682A1 (ja) |
MX (1) | MXPA03011983A (ja) |
WO (1) | WO2003002466A1 (ja) |
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004330146A (ja) * | 2003-05-09 | 2004-11-25 | Nippon Torimu:Kk | 活性水素溶存水の製造方法、その製造方法により得られる活性水素溶存水および発癌抑制剤 |
JP2004346053A (ja) * | 2003-05-19 | 2004-12-09 | Wataru Murota | 還元性化粧水及びその製造方法 |
JP2004351399A (ja) * | 2003-05-26 | 2004-12-16 | Wataru Murota | 還元水及びその製造方法 |
JP2005000901A (ja) * | 2003-06-12 | 2005-01-06 | Hiroshima Kasei Ltd | 水の酸化還元電位を−400mV〜−600mVに維持する方法 |
JP2005021875A (ja) * | 2003-07-03 | 2005-01-27 | Hiroshima Kasei Ltd | 水の酸化還元電位を維持する方法 |
JP2005040765A (ja) * | 2003-07-25 | 2005-02-17 | Wataru Murota | 抗酸化性水及び抗酸化性飲料 |
WO2005040047A1 (ja) * | 2003-10-27 | 2005-05-06 | Y.T.Magnet Co., Ltd. | 還元水素水の製造方法とその製造装置 |
WO2005039602A1 (ja) * | 2003-10-24 | 2005-05-06 | Miz Co., Ltd. | 薬理機能水、およびその用途 |
JP2005224696A (ja) * | 2004-02-12 | 2005-08-25 | Hoshizaki Electric Co Ltd | 防錆機能水、同防錆機能水の製造方法および製造装置 |
JP2005232015A (ja) * | 2004-02-17 | 2005-09-02 | Shoji Kubota | 酸性の還元水を用いた化粧水または化粧品 |
JP2005245427A (ja) * | 2004-02-05 | 2005-09-15 | Hiroshima Kasei Ltd | ゲル状機能性食品 |
JP2005270938A (ja) * | 2004-03-26 | 2005-10-06 | Ainobekkusu Kk | 水素濃縮水の製造方法および水素濃縮水 |
JP2005296939A (ja) * | 2004-03-15 | 2005-10-27 | Japan Organo Co Ltd | 活性酸素除去水の製造方法および製造装置 |
WO2006082655A1 (ja) * | 2005-02-07 | 2006-08-10 | Wataru Murota | 還元性の香水及びその製造方法 |
JP2006273730A (ja) * | 2005-03-28 | 2006-10-12 | Wataru Murota | 酸素含有型還元性生理食塩水又は酸素含有型還元性輸液及びその製造方法 |
JP2007077088A (ja) * | 2005-09-15 | 2007-03-29 | Hiroshima Kasei Ltd | 生理食塩水およびその製造方法 |
JP2007230964A (ja) * | 2006-03-03 | 2007-09-13 | Hiroshima Kasei Ltd | 化粧水および化粧水を製造する方法 |
JP2007268446A (ja) * | 2006-03-31 | 2007-10-18 | Sumitomo Heavy Industries Environment Co Ltd | 機能水の製造方法、機能水の使用方法及び機能水の製造装置 |
JP4022251B1 (ja) * | 2007-03-23 | 2007-12-12 | 九起商工株式会社 | 還元水生成装置 |
WO2008026785A1 (fr) * | 2006-08-31 | 2008-03-06 | Shigeo Ohta | Agent améliorant le métabolisme lipidique contenant une molécule d'hydrogène |
JPWO2006061880A1 (ja) * | 2004-12-06 | 2008-06-05 | 渉 室田 | 還元性化粧水及びその製造方法 |
WO2009084743A1 (ja) | 2007-12-28 | 2009-07-09 | Miz Co., Ltd. | 治療または予防のための外用剤 |
JP2010094622A (ja) * | 2008-10-17 | 2010-04-30 | Spring:Kk | 溶存水素飲料水の製造装置及びその製造方法 |
JP2010155867A (ja) * | 2010-04-05 | 2010-07-15 | Mizu Kk | 薬理機能水、およびその用途 |
WO2010092770A1 (ja) * | 2009-02-10 | 2010-08-19 | 株式会社志賀機能水研究所 | 活性水素溶存水の生成方法およびその生成具 |
JP2011190276A (ja) * | 2011-06-20 | 2011-09-29 | Mizu Kk | 薬理機能水、およびその用途 |
JP2014128796A (ja) * | 2009-02-10 | 2014-07-10 | Shiga Kinosui Kenkyusho:Kk | 活性水素溶存水の生成方法およびその生成具 |
JP2016172256A (ja) * | 2016-07-01 | 2016-09-29 | 有限会社 シリーズ | 動植物生体用活性水溶液の製造装置 |
JP2017000969A (ja) * | 2015-06-11 | 2017-01-05 | 株式会社ジェネライツ | 電解水の製造原料、それを用いた電解液、及び、その電解液から製造される電解水、並びに、その電解液及び電解水の製造方法 |
WO2018199099A1 (ja) * | 2017-04-26 | 2018-11-01 | 株式会社日本トリム | 電解水生成装置及び電解水生成方法 |
JP2019142859A (ja) * | 2018-02-23 | 2019-08-29 | ニプロ株式会社 | 血液ろ過用補充液 |
JP2020032387A (ja) * | 2018-08-31 | 2020-03-05 | 株式会社日本トリム | 電解水生成装置及び電解水生成方法 |
JP6928408B1 (ja) * | 2021-03-18 | 2021-09-01 | 株式会社ミスターウォーターマン | 整水システム及びそれに用いられる添加ユニット |
JP7029839B1 (ja) | 2021-03-18 | 2022-03-04 | 株式会社ミスターウォーターマン | 整水システム及びそれに用いられる添加ユニット |
JPWO2022249487A1 (ja) * | 2021-05-28 | 2022-12-01 | ||
JPWO2022249488A1 (ja) * | 2021-05-28 | 2022-12-01 |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7090878B2 (en) * | 2001-05-31 | 2006-08-15 | The Procter & Gamble Company | Mineral fortified water |
CA2468856C (en) | 2001-12-05 | 2011-07-26 | Osao Sumita | Method and apparatus for producing negative and positive oxidative reductive potential (orp) water |
US7838043B2 (en) * | 2003-02-20 | 2010-11-23 | Apt Co., Ltd | Superoxide anion decomposing agent |
US9168318B2 (en) | 2003-12-30 | 2015-10-27 | Oculus Innovative Sciences, Inc. | Oxidative reductive potential water solution and methods of using the same |
DE102004026918A1 (de) * | 2004-06-01 | 2005-12-22 | Robert Prosiegel | Elektrochemisch optimierte Lebensmittel |
US20080302651A1 (en) * | 2004-08-11 | 2008-12-11 | Miz Co., Ltd. | Performance Maintaining Method For Electrolyzed Functional Water Generating Apparatus |
WO2006021917A1 (en) * | 2004-08-23 | 2006-03-02 | Koninklijke Philips Electronics N.V. | Method and device for simulating a multi-layer optical storage medium |
KR101532778B1 (ko) | 2005-03-23 | 2015-06-30 | 오클루스 이노바티브 사이언시즈 인코포레이티드 | 산화 환원 전위 수용액을 사용한 2도 및 3도 화상의 치료방법 |
AU2006242175A1 (en) | 2005-05-02 | 2006-11-09 | Oculus Innovative Sciences, Inc. | Method of using oxidative reductive potential water solution in dental applications |
KR20080046177A (ko) * | 2005-08-19 | 2008-05-26 | 시게오 오타 | 생체 내의 유해한 활성 산소 및/또는 프리 라디칼 제거제 |
US20070196434A1 (en) | 2006-01-20 | 2007-08-23 | Oculus Innovative Sciences, Inc. | Methods of preventing or treating sinusitis with oxidative reductive potential water solution |
CN101600516B (zh) * | 2006-02-10 | 2012-08-08 | 坦南特公司 | 产生喷射的、电化学活化液体的方法和设备 |
JP5134793B2 (ja) * | 2006-08-04 | 2013-01-30 | 有限会社スプリング | 水中の溶存水素を活性化および安定化する方法 |
WO2008062814A1 (fr) * | 2006-11-24 | 2008-05-29 | Spring Co., Ltd. | Solution aqueuse dissoute dans l'hydrogène et procédé de prolongement de la durée de vie de l'hydrogène dissous dans la solution aqueuse |
US7639361B2 (en) * | 2007-05-14 | 2009-12-29 | Watkins Manufacturing Corporation | Apparatus for measuring chemical levels using pH shift |
US7671994B2 (en) * | 2007-05-14 | 2010-03-02 | Watkins Manufacturing Corporation | Method for measuring chemical levels using pH shift |
JP2009154030A (ja) * | 2007-12-25 | 2009-07-16 | Mikuni Corp | 電解水生成噴霧装置 |
KR100968908B1 (ko) * | 2008-05-02 | 2010-07-14 | 웅진코웨이주식회사 | 나노백금 콜로이드 이온수를 함유하는 화장료 조성물 |
JP4967001B2 (ja) * | 2009-03-13 | 2012-07-04 | ミズ株式会社 | 水素含有生体適用液の製造方法、及びそのための装置 |
WO2010148004A1 (en) | 2009-06-15 | 2010-12-23 | Oculus Innovative Sciences, Inc. | Solution containing hypochlorous acid and methods of using same |
JP6100752B2 (ja) * | 2013-07-25 | 2017-03-22 | 株式会社エイエムジー | 化粧料容器 |
CN104757672A (zh) * | 2015-03-20 | 2015-07-08 | 欢乐海(北京)水业科技有限公司 | 多极微动能饮用水在制备用于减肥的饮料、保健品或药物中的用途 |
CN105105256A (zh) * | 2015-07-22 | 2015-12-02 | 邓绍祥 | 富氢保健饮料及其制备方法 |
RU2620802C1 (ru) * | 2016-05-26 | 2017-05-29 | Александр Федорович Чабак | Устройство для наводораживания воды |
CN110319724A (zh) * | 2019-07-03 | 2019-10-11 | 江西华度电子新材料有限公司 | 一种恢复吸液芯毛细性能的方法 |
RU2722632C1 (ru) * | 2019-07-15 | 2020-06-02 | Федеральное государственное бюджетное научное учреждение "Поволжский научно-исследовательский институт производства и переработки мясомолочной продукции" (ГНУ НИИММП) | Способ получения водных растворов с отрицательным окислительно-восстановительным потенциалом |
KR102435483B1 (ko) | 2020-05-11 | 2022-08-25 | 주식회사 워터엔피플 | 구강 위생수 제조장치 |
CN115652108B (zh) * | 2022-10-31 | 2024-04-12 | 安徽工业大学 | 一种低共熔溶剂溶解回收钴酸锂的方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5781836A (en) * | 1980-11-07 | 1982-05-22 | Hitachi Ltd | Noble metal colloid catalyst |
JPH0458528A (ja) * | 1990-06-28 | 1992-02-25 | Ebara Res Co Ltd | 洗浄処理方法 |
JPH05317867A (ja) * | 1992-05-22 | 1993-12-03 | Japan Organo Co Ltd | 水中の酸化態窒素除去装置 |
US5403450A (en) * | 1990-09-26 | 1995-04-04 | Mobitec Molecular Biologische Technologie Gmbh | Method of water purification |
JPH07184667A (ja) * | 1993-12-24 | 1995-07-25 | Fuji Oil Co Ltd | 微生物を用いてアルコール類を製造する方法 |
JPH10225664A (ja) * | 1996-12-10 | 1998-08-25 | Japan Organo Co Ltd | ウェット処理装置 |
JP2001010954A (ja) * | 1999-06-29 | 2001-01-16 | Otsuka Sangyo Kk | 酸化的ストレスに対する保護剤 |
JP2001070944A (ja) * | 1998-11-25 | 2001-03-21 | Matsushita Electric Works Ltd | 電解水生成装置 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58153154A (ja) * | 1982-03-09 | 1983-09-12 | Ajinomoto Co Inc | 修飾電極 |
US5324491A (en) * | 1992-04-03 | 1994-06-28 | The United States Of America As Represented By The Secretary Of The Interior | Enzymatic reduction and precipitation of uranium |
CA2171481A1 (en) * | 1993-09-13 | 1995-03-23 | David Reznik | Apparatus and method for reducing the redox potential of substances |
US6325910B1 (en) * | 1994-04-08 | 2001-12-04 | Atotch Deutschland Gmbh | Palladium colloid solution and its utilization |
JP3481761B2 (ja) * | 1996-01-30 | 2003-12-22 | 忠正 中村 | 電解水の生成方法 |
DE19626697A1 (de) * | 1996-07-03 | 1998-01-08 | Bayer Ag | Verfahren zur Zerstörung oxidierender Substanzen in wäßrigen Flüssigkeiten |
JP3408394B2 (ja) * | 1996-08-27 | 2003-05-19 | 株式会社日本トリム | 電解水素溶存水の製造方法ならびにその製造装置 |
JPH11346715A (ja) * | 1998-06-09 | 1999-12-21 | Otsuka Yakuhin Kogyo Kk | 白金族コロイド溶液を配合した食品の製造方法 |
US6793883B2 (en) * | 2001-07-05 | 2004-09-21 | General Electric Company | Application of catalytic nanoparticles to high temperature water systems to reduce stress corrosion cracking |
-
2002
- 2002-06-28 BR BR0210726-0A patent/BR0210726A/pt not_active Application Discontinuation
- 2002-06-28 KR KR1020037017108A patent/KR100726057B1/ko not_active IP Right Cessation
- 2002-06-28 CN CNB028131681A patent/CN1296290C/zh not_active Expired - Fee Related
- 2002-06-28 WO PCT/JP2002/006560 patent/WO2003002466A1/ja active Application Filing
- 2002-06-28 KR KR1020077006751A patent/KR20070041639A/ko not_active Application Discontinuation
- 2002-06-28 CA CA002452682A patent/CA2452682A1/en not_active Abandoned
- 2002-06-28 MX MXPA03011983A patent/MXPA03011983A/es not_active Application Discontinuation
- 2002-06-28 JP JP2003508656A patent/JP4272054B2/ja not_active Expired - Fee Related
- 2002-06-28 US US10/480,265 patent/US20040154993A1/en not_active Abandoned
- 2002-06-28 EP EP02741360A patent/EP1413555A4/en not_active Withdrawn
-
2009
- 2009-04-13 US US12/422,737 patent/US20090196863A1/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5781836A (en) * | 1980-11-07 | 1982-05-22 | Hitachi Ltd | Noble metal colloid catalyst |
JPH0458528A (ja) * | 1990-06-28 | 1992-02-25 | Ebara Res Co Ltd | 洗浄処理方法 |
US5403450A (en) * | 1990-09-26 | 1995-04-04 | Mobitec Molecular Biologische Technologie Gmbh | Method of water purification |
JPH05317867A (ja) * | 1992-05-22 | 1993-12-03 | Japan Organo Co Ltd | 水中の酸化態窒素除去装置 |
JPH07184667A (ja) * | 1993-12-24 | 1995-07-25 | Fuji Oil Co Ltd | 微生物を用いてアルコール類を製造する方法 |
JPH10225664A (ja) * | 1996-12-10 | 1998-08-25 | Japan Organo Co Ltd | ウェット処理装置 |
JP2001070944A (ja) * | 1998-11-25 | 2001-03-21 | Matsushita Electric Works Ltd | 電解水生成装置 |
JP2001010954A (ja) * | 1999-06-29 | 2001-01-16 | Otsuka Sangyo Kk | 酸化的ストレスに対する保護剤 |
Cited By (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004330146A (ja) * | 2003-05-09 | 2004-11-25 | Nippon Torimu:Kk | 活性水素溶存水の製造方法、その製造方法により得られる活性水素溶存水および発癌抑制剤 |
JP2004346053A (ja) * | 2003-05-19 | 2004-12-09 | Wataru Murota | 還元性化粧水及びその製造方法 |
JP2004351399A (ja) * | 2003-05-26 | 2004-12-16 | Wataru Murota | 還元水及びその製造方法 |
JP2005000901A (ja) * | 2003-06-12 | 2005-01-06 | Hiroshima Kasei Ltd | 水の酸化還元電位を−400mV〜−600mVに維持する方法 |
JP2005021875A (ja) * | 2003-07-03 | 2005-01-27 | Hiroshima Kasei Ltd | 水の酸化還元電位を維持する方法 |
JP2005040765A (ja) * | 2003-07-25 | 2005-02-17 | Wataru Murota | 抗酸化性水及び抗酸化性飲料 |
JP4653945B2 (ja) * | 2003-10-24 | 2011-03-16 | ミズ株式会社 | 薬理機能水、およびその用途 |
WO2005039602A1 (ja) * | 2003-10-24 | 2005-05-06 | Miz Co., Ltd. | 薬理機能水、およびその用途 |
JP2005126384A (ja) * | 2003-10-24 | 2005-05-19 | Mizu Kk | 薬理機能水、およびその用途 |
WO2005040047A1 (ja) * | 2003-10-27 | 2005-05-06 | Y.T.Magnet Co., Ltd. | 還元水素水の製造方法とその製造装置 |
JP2005245427A (ja) * | 2004-02-05 | 2005-09-15 | Hiroshima Kasei Ltd | ゲル状機能性食品 |
JP2005224696A (ja) * | 2004-02-12 | 2005-08-25 | Hoshizaki Electric Co Ltd | 防錆機能水、同防錆機能水の製造方法および製造装置 |
JP2005232015A (ja) * | 2004-02-17 | 2005-09-02 | Shoji Kubota | 酸性の還元水を用いた化粧水または化粧品 |
JP2005296939A (ja) * | 2004-03-15 | 2005-10-27 | Japan Organo Co Ltd | 活性酸素除去水の製造方法および製造装置 |
JP2005270938A (ja) * | 2004-03-26 | 2005-10-06 | Ainobekkusu Kk | 水素濃縮水の製造方法および水素濃縮水 |
JPWO2006061880A1 (ja) * | 2004-12-06 | 2008-06-05 | 渉 室田 | 還元性化粧水及びその製造方法 |
WO2006082655A1 (ja) * | 2005-02-07 | 2006-08-10 | Wataru Murota | 還元性の香水及びその製造方法 |
JPWO2006082655A1 (ja) * | 2005-02-07 | 2008-06-26 | 渉 室田 | 還元性の香水及びその製造方法 |
JP2006273730A (ja) * | 2005-03-28 | 2006-10-12 | Wataru Murota | 酸素含有型還元性生理食塩水又は酸素含有型還元性輸液及びその製造方法 |
JP2007077088A (ja) * | 2005-09-15 | 2007-03-29 | Hiroshima Kasei Ltd | 生理食塩水およびその製造方法 |
JP2007230964A (ja) * | 2006-03-03 | 2007-09-13 | Hiroshima Kasei Ltd | 化粧水および化粧水を製造する方法 |
JP4600889B2 (ja) * | 2006-03-03 | 2010-12-22 | 広島化成株式会社 | 化粧水を製造する方法 |
JP2007268446A (ja) * | 2006-03-31 | 2007-10-18 | Sumitomo Heavy Industries Environment Co Ltd | 機能水の製造方法、機能水の使用方法及び機能水の製造装置 |
WO2008026785A1 (fr) * | 2006-08-31 | 2008-03-06 | Shigeo Ohta | Agent améliorant le métabolisme lipidique contenant une molécule d'hydrogène |
JPWO2008026785A1 (ja) * | 2006-08-31 | 2010-01-21 | 太田 成男 | 水素分子を含む脂質代謝改善剤 |
WO2008117387A1 (ja) * | 2007-03-23 | 2008-10-02 | Kuki-Shoukou, Co., Ltd. | 還元水生成装置 |
JP4022251B1 (ja) * | 2007-03-23 | 2007-12-12 | 九起商工株式会社 | 還元水生成装置 |
WO2009084743A1 (ja) | 2007-12-28 | 2009-07-09 | Miz Co., Ltd. | 治療または予防のための外用剤 |
JP2010094622A (ja) * | 2008-10-17 | 2010-04-30 | Spring:Kk | 溶存水素飲料水の製造装置及びその製造方法 |
WO2010092770A1 (ja) * | 2009-02-10 | 2010-08-19 | 株式会社志賀機能水研究所 | 活性水素溶存水の生成方法およびその生成具 |
JP2010207802A (ja) * | 2009-02-10 | 2010-09-24 | Shiga Kinosui Kenkyusho:Kk | 活性水素溶存水の生成方法およびその生成具 |
JP2014128796A (ja) * | 2009-02-10 | 2014-07-10 | Shiga Kinosui Kenkyusho:Kk | 活性水素溶存水の生成方法およびその生成具 |
JP2010155867A (ja) * | 2010-04-05 | 2010-07-15 | Mizu Kk | 薬理機能水、およびその用途 |
JP2011190276A (ja) * | 2011-06-20 | 2011-09-29 | Mizu Kk | 薬理機能水、およびその用途 |
JP2017000969A (ja) * | 2015-06-11 | 2017-01-05 | 株式会社ジェネライツ | 電解水の製造原料、それを用いた電解液、及び、その電解液から製造される電解水、並びに、その電解液及び電解水の製造方法 |
JP2016172256A (ja) * | 2016-07-01 | 2016-09-29 | 有限会社 シリーズ | 動植物生体用活性水溶液の製造装置 |
WO2018199099A1 (ja) * | 2017-04-26 | 2018-11-01 | 株式会社日本トリム | 電解水生成装置及び電解水生成方法 |
JP2018183740A (ja) * | 2017-04-26 | 2018-11-22 | 株式会社日本トリム | 電解水生成装置 |
JP2019142859A (ja) * | 2018-02-23 | 2019-08-29 | ニプロ株式会社 | 血液ろ過用補充液 |
JP7246203B2 (ja) | 2018-02-23 | 2023-03-27 | ニプロ株式会社 | 血液ろ過用補充液 |
JP2020032387A (ja) * | 2018-08-31 | 2020-03-05 | 株式会社日本トリム | 電解水生成装置及び電解水生成方法 |
WO2020045063A1 (ja) * | 2018-08-31 | 2020-03-05 | 株式会社日本トリム | 電解水生成装置及び電解水生成方法 |
JP6928408B1 (ja) * | 2021-03-18 | 2021-09-01 | 株式会社ミスターウォーターマン | 整水システム及びそれに用いられる添加ユニット |
JP7029839B1 (ja) | 2021-03-18 | 2022-03-04 | 株式会社ミスターウォーターマン | 整水システム及びそれに用いられる添加ユニット |
WO2022196808A1 (ja) * | 2021-03-18 | 2022-09-22 | 株式会社ミスターウォーターマン | 整水システム及びそれに用いられる添加ユニット |
JP2022143857A (ja) * | 2021-03-18 | 2022-10-03 | 株式会社ミスターウォーターマン | 整水システム及びそれに用いられる添加ユニット |
JP2022145418A (ja) * | 2021-03-18 | 2022-10-04 | 株式会社ミスターウォーターマン | 整水システム及びそれに用いられる添加ユニット |
JPWO2022249487A1 (ja) * | 2021-05-28 | 2022-12-01 | ||
WO2022249487A1 (ja) * | 2021-05-28 | 2022-12-01 | 中国電力株式会社 | 放水方法、水処理方法、残留塩素低減方法及び水処理設備 |
JPWO2022249488A1 (ja) * | 2021-05-28 | 2022-12-01 |
Also Published As
Publication number | Publication date |
---|---|
KR20070041639A (ko) | 2007-04-18 |
MXPA03011983A (es) | 2004-03-26 |
BR0210726A (pt) | 2004-07-20 |
KR100726057B1 (ko) | 2007-06-08 |
CN1522229A (zh) | 2004-08-18 |
US20090196863A1 (en) | 2009-08-06 |
EP1413555A1 (en) | 2004-04-28 |
CN1296290C (zh) | 2007-01-24 |
KR20040030715A (ko) | 2004-04-09 |
EP1413555A4 (en) | 2005-10-05 |
JPWO2003002466A1 (ja) | 2004-10-14 |
CA2452682A1 (en) | 2003-01-09 |
JP4272054B2 (ja) | 2009-06-03 |
US20040154993A1 (en) | 2004-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4272054B2 (ja) | 抗酸化方法、および抗酸化機能水 | |
JP4511361B2 (ja) | 被検定水の溶存水素濃度の定量分析方法及び装置 | |
JP4653945B2 (ja) | 薬理機能水、およびその用途 | |
RU2492146C2 (ru) | Способ обогащения воды кислородом посредством электролитического процесса, вода или напиток, обогащенные кислородом, и их применение | |
JP5134793B2 (ja) | 水中の溶存水素を活性化および安定化する方法 | |
Goncharuk et al. | The use of redox potential in water treatment processes | |
CA2377232A1 (en) | Prophylactic, therapeutic and industrial antioxidant compositions enhanced with stabilized atomic hydrogen/free electrons and methods to prepare and use such compositions | |
JP4783466B2 (ja) | 薬理機能水、およびその用途 | |
JP2011190276A (ja) | 薬理機能水、およびその用途 | |
Ling et al. | ROS generation strategy based on biomimetic nanosheets by self-assembly of nanozymes | |
Beloussov et al. | Fundamental role of water in bioenergetics | |
JP2003026406A (ja) | ヒドロキシラジカルの製造方法 | |
TWI270532B (en) | Method for antioxidation and antioxidative functional water | |
TW200413503A (en) | Method of inhibiting oxidation, water capable of inhibiting oxidation and use thereof | |
JP2013047242A (ja) | 活性酸素除去剤、血圧降下剤、血糖値低下剤、肌状態改善剤および肥満防止剤 | |
Voeikov | Voeikov VL, Martynyuk VS., eds, Springer, 2007, pp. 89-104. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003508656 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1-2003-501304 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10480265 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2003/011983 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 028131681 Country of ref document: CN Ref document number: 2452682 Country of ref document: CA Ref document number: 2289/DELNP/2003 Country of ref document: IN Ref document number: 1020037017108 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002315740 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002741360 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200400672 Country of ref document: ZA |
|
WWP | Wipo information: published in national office |
Ref document number: 2002741360 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077006751 Country of ref document: KR |